Nothing Special   »   [go: up one dir, main page]

WO2007114447A1 - Medical liquid injecting device - Google Patents

Medical liquid injecting device Download PDF

Info

Publication number
WO2007114447A1
WO2007114447A1 PCT/JP2007/057494 JP2007057494W WO2007114447A1 WO 2007114447 A1 WO2007114447 A1 WO 2007114447A1 JP 2007057494 W JP2007057494 W JP 2007057494W WO 2007114447 A1 WO2007114447 A1 WO 2007114447A1
Authority
WO
WIPO (PCT)
Prior art keywords
injection
graph
chemical
pressure
time
Prior art date
Application number
PCT/JP2007/057494
Other languages
French (fr)
Japanese (ja)
Inventor
Shigeru Nemoto
Original Assignee
Nemoto Kyorindo Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nemoto Kyorindo Co., Ltd. filed Critical Nemoto Kyorindo Co., Ltd.
Priority to JP2008508704A priority Critical patent/JPWO2007114447A1/en
Publication of WO2007114447A1 publication Critical patent/WO2007114447A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14546Front-loading type injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/18General characteristics of the apparatus with alarm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1456Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/281Means for the use of in vitro contrast agents

Definitions

  • the present invention relates to a chemical injection device for injecting a chemical into a subject, and in particular, a CT (Computed Tomography) scanner or an MRI (Magnetic Magnetic).
  • a CT Computer Tomography
  • MRI Magnetic Magnetic
  • Such a chemical solution injection device has, for example, a piston drive mechanism including a drive motor and a slider mechanism, and a chemical solution syringe is detachably attached thereto.
  • the chemical syringe includes a cylinder member and a piston member that is slidably inserted into the slider member.
  • the cylinder member is filled with a chemical solution such as contrast medium or physiological saline.
  • the chemical injection device pushes the cylinder member into the piston member by the piston drive mechanism, thereby using the chemical syringe syringe.
  • a contrast medium is injected into the subject.
  • the liquid injection apparatus applies the contrast medium according to the input numerical values. Inject the subject. Since the contrast level of the subject changes due to the injection of the contrast agent, a good fluoroscopic image is taken by the fluoroscopic imaging device.
  • a contrast agent syringe filled with a contrast agent and a physiological saline syringe filled with physiological saline are mounted in parallel as a chemical solution syringe. It is.
  • the contrast syringe and the saline syringe are usually connected to the subject by a single bifurcated extension tube.
  • the chemical solution injection device receives the input data.
  • a contrast medium is injected into the subject and then physiological saline is also injected automatically.
  • the contrast agent can be boosted with physiological saline to reduce the consumption of the contrast agent, and the artifact can be reduced with the physiological saline.
  • the detected pressure rapidly decreases. Also, if the extension tube bends during the test injection, the detected pressure rises rapidly. Since the chemical injection device displays the pressure of the chemical to be injected in real time, the operator can judge the occurrence of abnormality by monitoring the pressure.
  • the test injection for confirming the connection state of the extension tube is performed by injection of a contrast medium in a chemical liquid injection apparatus in which only a contrast medium syringe is mounted, and the contrast medium syringe and the physiological saline syringe are connected.
  • the chemical injection device is usually implemented by injection of physiological saline.
  • test injection for confirming the time required for the contrast medium to reach the affected area is also executed.
  • contrast medium is injected at the same rate as normal injection, and the time required from the start of injection until the contrast medium reaches the affected area is measured.
  • an injection head to which a chemical solution syringe is attached;
  • the injection control unit in which display and input operations are executed is configured separately. Therefore, the injection head can be freely arranged in the vicinity of the subject, and the injection control unit can be arranged in the vicinity of the imaging control device of the fluoroscopic imaging device. [0012] In particular, when the fluoroscopic imaging apparatus is an MRI apparatus, the injection control unit with a built-in microcomputer cannot be arranged in the vicinity of the fluoroscopic imaging unit of the MRI apparatus. A structure that can be arranged separately from the control unit is useful.
  • the present applicant has a structure in which the injection head and the injection control unit are separated, and the test injection input operation and display are executed by the injection head, and the formal injection input operation and display are performed.
  • has been filed by inventing a chemical solution injection device that improves the workability of test injection and formal injection by executing the injection control unit see, for example, Patent Document 1).
  • Patent Document 1 Japanese Patent Application No. 2003-368859 (WO2005 / 039675A1)
  • the chemical injection device as described above displays the pressure of the chemical to be injected in real time, the operator can determine whether there is an abnormality by monitoring the pressure. However, in other words, if the operator does not monitor the pressure displayed by the chemical injection device, the occurrence of an abnormality will not be determined, and the burden on the operator is heavy and the detection of the occurrence of the abnormality may be delayed.
  • a predetermined allowable range is set for the chemical injection device with respect to the test injection pressure, and the chemical injection device detects an abnormality when the detected pressure deviates from the allowable range. it can.
  • the force that needs to be confirmed when the detected pressure changes suddenly while satisfying the allowable range, etc.
  • the chemical injection device as described above, the allowable range is satisfied even if the pressure changes suddenly. If so, the occurrence of an abnormality is not detected.
  • the present invention has been made in view of the above-described problems, and even when the pressure of the test injection is suddenly changed within a predetermined range or when the change pattern of the pressure is changed.
  • An object of the present invention is to provide a chemical liquid injector capable of detecting abnormal occurrences satisfactorily.
  • the chemical injection device of the present invention is a chemical liquid syringe force in which a piston member is slidably inserted into a cylinder member.
  • the chemical injection device is a piston drive mechanism, pressure detection means, graph generation means, graph storage means, graph comparison means, abnormality detection means, and warning notification means.
  • the piston drive mechanism pushes the piston member into the cylinder member.
  • the pressure detection means detects the pressure of the chemical solution injected into the subject.
  • the graph generating means generates the pressure detected during execution of the test injection in real time as a time graph.
  • the graph storage means stores a reference graph corresponding to the pressure when the test injection is properly executed.
  • the graph comparison means compares the shape of the time graph with the shape of the reference graph in real time.
  • the abnormality detection means detects the occurrence of an abnormality if the shape of the time-dependent graph is not similar to the shape of the reference graph.
  • the time-lapse graph and the reference graph are compared by the existing image recognition technology, and if the reference graph and the time-lapse graph are not similar, the occurrence of abnormality is detected. Therefore, the occurrence of an abnormality is detected even when the pressure of the test injection changes rapidly within a predetermined range or when the pressure change pattern is changed.
  • the various means referred to in the present invention may be formed so as to realize their functions!
  • dedicated hardware that exhibits a predetermined function, and a predetermined function provided by a computer program.
  • the various constituent elements referred to in the present invention are not necessarily required to be individually independent, but a plurality of constituent elements are formed as one member, and one constituent element includes a plurality of constituent elements. It is possible to be formed of members, a certain component is a part of another component, a part of a certain component overlaps a part of another component, etc. Brief description of the drawings
  • FIG. 1 is a schematic diagram showing a logical structure of a chemical liquid injector according to an embodiment of the present invention.
  • FIG. 2 is a block diagram showing a physical structure of a chemical solution injection system.
  • FIG. 3 is a perspective view showing an appearance of a chemical liquid injection system.
  • ⁇ 4 It is a perspective view showing the appearance of the chemical liquid injector.
  • ⁇ 5 A perspective view showing a state in which a chemical syringe is attached to the injection head of the chemical injection device.
  • ⁇ 6 A schematic cross-sectional view showing the internal structure of the injection head.
  • FIG. 7 is a diagram showing an example of a display screen of a sub touch panel that serves as both a sub operation panel and a sub display panel.
  • FIG. 8 is a diagram showing a state in which a schematic image of a body section and a blank condition screen are displayed on a main touch panel that serves as both a main operation panel and a main display panel.
  • FIG. 9 is a diagram showing a display screen of the main touch panel in a state where the body classification is selected.
  • FIG. 10 is a diagram showing a display screen of the main touch panel in a state in which an imaging region is selected and a condition image is displayed.
  • FIG. 11 is a flowchart showing an early part of the processing operation of the chemical injection device.
  • FIG. 12 is a flowchart showing the middle part of the processing operation of the chemical injection device.
  • FIG. 13 is a flowchart showing an end portion of the processing operation of the chemical liquid injector.
  • FIG. 14 is a flowchart showing a processing operation of an MRI apparatus which is a fluoroscopic imaging apparatus. Explanation of symbols
  • a chemical injection system 1000 includes a chemical injection device 100, a chemical syringe 200, and an MRI apparatus 300 that is a fluoroscopic imaging device. As will be described later, a contrast medium or the like is injected into the subject (not shown) as a drug solution.
  • the MRI apparatus 300 includes a fluoroscopic imaging unit 301 and an imaging control unit 302.
  • the fluoroscopic imaging unit 301 and the imaging control unit 302 are connected to each other through a communication network 303.
  • the fluoroscopic imaging unit 301 captures a fluoroscopic image from the subject, and the imaging control unit 302 controls the operation of the fluoroscopic imaging unit 301.
  • the chemical syringe 200 has a cylinder member 210 and a piston member 220 as shown in FIG.
  • the piston member 220 is slidably inserted into the cylinder member 210.
  • the cylinder member 210 has a cylindrical main body 211, and a conduit 212 is formed on the closed end face of the main body 211.
  • the end face of the main body 211 of the cylinder member 210 is opened, and the piston member 220 is inserted into the main body 211 from this opening.
  • a cylinder flange 213 is formed on the outer periphery of the cylinder member 210, and a piston flange 221 is formed on the outer periphery of the piston member 220.
  • the chemical injection device 100 of the present embodiment includes an injection control unit 101, and an injection head 110 that is an injection device body configured separately from the injection control unit 101. Yes.
  • Injection control unit 101 and injection head 110 are wire-connected with communication cable 102.
  • the injection head 110 drives the chemical solution syringe 200 to be attached to inject the chemical solution into the subject.
  • the injection control unit 101 controls the operation of the injection head 110.
  • the injection control unit 101 has a computer unit 120 built therein.
  • the computer unit 120 is also connected to the imaging control unit 302 of the MRI apparatus 300 through a communication network 304 by wire.
  • the injection control unit 101 includes a main operation panel 103, a main touch panel 104 that combines the operation unit and the main display panel, a speaker unit 105, and the like arranged on the front surface of the main body housing 106.
  • a separate controller unit 107 is wired with a connection cable 108.
  • the injection head 110 is attached to the upper end of the caster stand 111 via the movable arm 112. As shown in FIG. 5, the injection head 110 has a head main body 113, and a semicylindrical groove-shaped concave portion 114 that holds the chemical syringe 200 is formed on the upper surface of the head main body 113. ing.
  • a cylinder holding mechanism 116 that holds the cylinder flange 213 of the chemical liquid syringe 200 is formed in the front part of the recess 114.
  • a piston drive mechanism 130 that holds and slides the piston flange 221 is disposed behind the recess 114.
  • the cylinder holding mechanism 116 has a concave groove formed in the inner surface of the concave portion 114, and the cylinder flange 213 is engaged with the concave groove.
  • the two concave portions 114 of the injection head 110 are individually provided with a contrast medium syringe 200C filled with a contrast medium as a chemical solution and a physiological saline syringe 200P filled with a physiological saline solution as a chemical liquid! It is attached to.
  • the piston drive mechanism 130 is disposed corresponding to each recess 114.
  • the two recesses 114 and the two piston drive mechanisms 130 constitute a contrast medium injection mechanism 130C for injecting a contrast medium into a subject and a physiological saline injection mechanism 130P for injecting physiological saline.
  • the piston drive mechanism 130 has a slide rod 131 that is elongated in the front-rear direction as a slider member.
  • the slide rod 131 is supported by the head body 113 so as to be slidable in the front-rear direction in a state in which the slide rod 131 cannot rotate about the axis.
  • a piston pressing member 132 is formed in the body at the front end of the slide rod 131.
  • a pair of engaging claws 133 are attached to the piston pressing member 132 so as to be freely opened and closed.
  • a threaded hole 134 is formed in the slide rod 131 such that the center force on the rear surface is also directed forward.
  • a male screw 136 that engages with the screw hole 134 is formed on a screw shaft 137 that is a rotating member.
  • the screw shaft 137 is rotatably supported on the head body 113 by a radial bearing 138, and is supported by the thrust bearing 139 in the axial direction in a rotatable state. More specifically, an annular flange portion 141 is formed near the rear end of the screw shaft 137, and an annular thrust bearing 139 is in contact with the rear surface of the flange portion 141.
  • a load cell 142 having the same shape is in contact with the rear surface of the thrust bearing 139 as a pressure detection element.
  • the load cell 142 is a force fixed to the head main body 113.
  • the thrust bearing 139 is supported by the head main body 113 so as to be slightly displaceable in the front-rear direction.
  • the piston drive mechanism 130 has an ultrasonic motor 143 as a drive motor, and the ultrasonic motor 143 includes a belt mechanism 144 and a screw shaft 137 as shown in FIG. It is connected to. More specifically, a belt wheel 145 is attached to the rear end of the screw shaft 137, and a belt wheel is also attached to the rotor member of the ultrasonic motor 143 (not shown). An endless belt 146 is stretched around these belt wheels 145.
  • each part of the injection head 110 is formed of a nonmagnetic material, and a portion that cannot be formed of a nonmagnetic material is shielded.
  • the ultrasonic motor 143 has phosphor bronze alloy (Cu + Sn + P), titanium alloy ( ⁇ -6 ⁇ ⁇ 4V), magnesium alloy (Mg + Al + Zn), It is made of non-magnetic metal such as.
  • the load cell 142, the screw, the shaft 137, etc. are made of non-magnetic metal.
  • the belt mechanism 144 and the head body 113 are made of non-magnetic grease.
  • the main operation panel 103, the load cell 142, and the like are connected to the computer unit 120, and each part is integrated and controlled in accordance with the computer program installed in the computer unit 120 force. To do. Because of this, injection control The computer unit 120 controls the operation of the piston drive mechanism 130 of the injection head 110 in response to input operations of the main operation panel 103, main touch panel 104, and controller unit 107 of the unit 101, and various data related to this control are stored in the computer. The unit 120 is displayed on the main touch panel 104.
  • a sub-touch panel 118 serving as both a sub-operation panel and a sub-display panel is attached to the side of the injection head 110!
  • the computer unit 120 also controls the operation of the piston drive mechanism 130 of the injection head 110 and displays various data related to this control on the sub-touch panel 118 even when the sub-touch panel 118 is input.
  • the force sub-touch panel 118 which will be described in detail later, has a smaller screen size and fewer pixels than the main touch panel 104, the amount of data that can be displayed is small. For this reason, all of the various data that need to be displayed is displayed on the main touch panel 104. Only a part is displayed on the sub touch panel 118.
  • the computer unit 120 includes a CPU (Central Processing Unit) 121, a ROM (Read Only Memory) 122, a RAM (Rando m
  • a dedicated computer program is mounted on an information storage medium such as the ROM 122 by firmware or the like, and the CPU 121 executes various processing operations corresponding to the computer program.
  • the chemical injection device 100 of this embodiment stores various data of formal injection on the main touch panel 104.
  • the input operation is performed and displayed on the main touch panel 104, and various data of the test injection are input on the sub touch panel 118 and displayed on the sub touch panel 118.
  • the control data of the piston drive mechanism 130 specially designed for confirming the connection state of the extension tube 230 is registered as various types of test injection data.
  • the test touch start command is input to the sub touch panel 118. Then, the operation of the ultrasonic motor 143 of the physiological saline injection mechanism 130P is controlled corresponding to the test injection control data.
  • the chemical injection device 100 of the present embodiment is configured such that the computer unit 120 operates in response to the computer program and the control data for the test injection, so that the pressure detection means 151, the graph generation means 152, the graph storage Means 153, graph display means 154, graph comparison means 156, abnormality detection means 157, warning notification means 158, drive control means 159, input operation means 161, graph registration means 162, etc.
  • Each of these means uses hardware such as the load cell 142 and the sub-touch panel 104 as a part if necessary, but basically the CPU 121 performs predetermined data processing corresponding to the computer program in the ROM 122. It corresponds to the function to execute.
  • the pressure detection means 151 detects the pressure of the chemical solution injected into the subject from the detection pressure of the load cell 142.
  • the graph generating means 152 generates the pressure detected during the test injection in real time as a time graph.
  • the graph storage means 153 corresponds to a storage area of the RAM 123 constructed so that the CPU 121 can recognize, and stores a reference graph corresponding to the pressure when the test injection is properly executed.
  • the graph display means 154 displays the stored reference graph on the sub-touch panel 118 and also displays the generated time-lapse graph in real time.
  • the graph comparison means 156 compares the shape of the time-lapse graph with the shape of the reference graph in real time using an existing image recognition technique or the like.
  • the abnormality detection means 157 detects the occurrence of an abnormality if the shape of the time graph and the reference graph are not similar.
  • the warning notification unit 158 displays that the abnormality has occurred on the main touch panel 104 and the sub touch panel 118 and outputs the sound from the speaker unit 105 as a sound. Will issue a warning.
  • the drive control means 159 controls the operation of the piston drive mechanism 130 corresponding to the reference graph when the test injection is executed, and forcibly stops the piston drive mechanism 130 when an abnormality is detected by the abnormality detection means 157.
  • the input operation unit 161 sets the abnormality detection unit 157 in a state in which an abnormality has been detected in response to a predetermined input operation to the sub-touch panel 118.
  • the graph registration means 162 is a sub-touch By a predetermined input operation on the panel 118, the time graph is registered in the graph storage means 153 as a reference graph.
  • the various means of the chemical solution injection device 100 as described above are forces realized by using hardware such as the main touch panel 104 as necessary.
  • the main body is a computer program stored in an information storage medium such as the ROM 122. This is realized by the function of the CPU 121, which is hardware, corresponding to the above.
  • Such a computer program stores, for example, a reference graph corresponding to the pressure when the test injection is properly executed in the RAM 123, and the piston corresponding to the reference graph when the test injection is executed.
  • Control the operation of the drive mechanism 130 detect the pressure of the chemical injected into the subject during the test injection from the detection pressure of the load cell 142, generate the detected pressure in real time as a graph over time, subtouch panel Display the reference graph in 118 and display the time graph in real time, compare the shape of the time graph with the shape of the reference graph in real time using existing image recognition technology, etc., and the shape of the time graph and the reference graph are similar Otherwise, the occurrence of an abnormality will be detected and the corresponding input operation to the sub touch panel 118 will be supported.
  • the main touch panel 104 and sub touch panel 118 display and the sound of the speaker unit 105 will give a warning, and if an abnormality is detected, the piston will drive.
  • processing operations such as forcibly stopping the mechanism 130 and registering a time-dependent graph as a reference graph by a predetermined input operation to the sub-touch panel 118, it is stored in an information storage medium such as the RAM 123. Stored.
  • the injection head 110 of the liquid injector 100 is arranged in the vicinity of the fluoroscopic imaging unit 301 of the MRI apparatus 300 as shown in FIG.
  • the injection control unit 101 is disposed at a predetermined position away from the fluoroscopic imaging unit 301.
  • Step Sl the operator moves from the vicinity of the injection head 110 to the vicinity of the injection control unit 101, and activates the chemical injection device 100 by an input operation on the main operation panel 103 or the like. Then, as shown in FIG. 8 and FIG. 11, a schematic image of a plurality of body sections is displayed on the upper part of the main touch panel 104 corresponding to the human body shape, and the injection rate of the medicinal solution is displayed below it. A horizontally long condition screen with the vertical axis and injection time on the horizontal axis is displayed (Step Sl).
  • step S2 when one of the schematic images of the plurality of body sections displayed on the main touch panel 104 is selected by the operator touching with a finger (step S2), the selection is performed as shown in FIG. Only the schematic image of the selected body section is brightened and the other schematic images are darkened, and the schematic image of the scanner mechanism is displayed above the schematic image of the selected body section.
  • a schematic image of a plurality of imaging regions related to the selected body segment is read and displayed at the bottom (steps S3 and S4), one of which is manually performed by the operator.
  • step S5 When selected by touching (step S5), as shown in FIG. 10, only one selected schematic image is brightened and the other schematic images are darkened.
  • step S7 When an imaging region is selected as described above, in the chemical injection device 100 of the present embodiment, it is confirmed whether or not a plurality of types of chemical syringes 200 are registered in the RAM 123 corresponding to the imaging region (step If a plurality of types of liquid syringes 200 are registered, product names and capacities that are identification data are listed in the main touch panel 104 and the sub touch panel 118 (step S7).
  • the display data of the selected chemical syringe 200 is erased, and the display data of only the selected chemical syringe 200 is expanded, so that the operator confirms the selection result of the chemical syringe 200 with certainty. can do.
  • the liquid injector 100 of the present embodiment stores the liquid syringe 200 that was used last time, and the liquid syringe 200 that was used last time is displayed by blinking or inversion when displayed as a list. The operator can easily execute the selection operation when the chemical syringe 200 to be used is the same as the previous one.
  • the selection operation of the chemical syringe 200 can also be performed on the sub-touch panel 118 of the injection head 110, the contrast medium syringe 200C and the physiological saline syringe 200P that are actually attached to the injection head 110 are installed. It is also possible to execute the selection operation with the sub touch panel 118 while confirming.
  • step S6 If only the contrast medium syringe 200C and the physiological saline syringe 200P force type are registered corresponding to the imaging site (step S6), the various types of data of the drug syringe 200 are automatically read out.
  • the product name, capacity, etc. are enlarged and displayed on the main touch panel 104 and the sub touch panel 118 (step S9).
  • the previous injection conditions for the formal injection correspond to the imaging region and the chemical syringe 200. It is confirmed whether it is registered in RAMI 23 (step S 10), registered !, na! /, And the default injection conditions are read (step Sl l). The injection condition is read (step S12).
  • the contrast agent and the physiological saline are sequentially used in the formal injection.
  • the injection conditions of contrast medium and physiological saline are registered so that this injection is executed. Since the injection time and the injection rate are set as data for the injection conditions read out in this way, the injection time and the injection speed are multiplied to calculate the injection volume for each injection condition (step S13).
  • a condition image in which the injection speed and the injection volume are given as text data in a width corresponding to the injection time is generated for each injection condition (step S14), and as shown in FIG.
  • the image is displayed and output on the condition screen at a vertical position corresponding to the injection speed and a horizontal position corresponding to the injection time (step S17).
  • the condition image is also generated for the injection condition force of the contrast medium and the physiological saline as described above.
  • the condition image is displayed and output in green and blue, and sequentially in the horizontal direction. Are displayed and output.
  • it is determined for each injection condition whether the injection speed exceeds the upper limit speed (step S15) .If the injection speed exceeds, the condition image flashes in red and a speed warning is issued. Is output (step S16).
  • the chemical injection device 100 of the present embodiment can change the injection conditions displayed on the main touch panel 104 as described above by operating the main touch panel 104 as desired. Yes (Steps S18, S19).
  • the injection speed of the injection condition can be increased or decreased by bringing the finger into contact with the center of the condition image displayed on the main touch panel 104 and sliding the contacted finger up or down on the condition image. .
  • the injection time and the injection volume of the injection conditions can be increased or decreased by bringing a finger into contact with at least one of the left and right ends of the displayed condition image and sliding the contacted finger to the left or right.
  • an operation image of the numeric keypad is displayed there (not shown). The rate and volume of injection can be increased or decreased.
  • step S18 when the injection condition for formal injection is input by the condition image displayed on the main touch panel 104 (step S18), this is stored as the current injection condition (step S12). A condition image is generated in real time corresponding to the condition (steps 313 to 319).
  • the injection conditions for formal injection are determined as described above.
  • the force registered in the RAM 123 as the reference graph is confirmed as the time chart of the test injection (step S20).
  • the time graph is registered, in this case, the default graph corresponding to the imaging region and the chemical syringe 200 is read, and the reference graph is read and displayed on the sub touch panel 118 (step S23). ). On the other hand, if a time-dependent graph is registered corresponding to the imaging region and the chemical syringe 200, the time-dependent graph is read and displayed as a reference graph on the sub-touch panel 118 (step S21).
  • the sub-touch panel 118 “executes test injection with user settings.
  • the default reference graph and the time graph registered as the reference graph are displayed along with guidance messages such as “YZN”. For this reason, the operator can also select and operate the power to use the registered time graph or the default reference graph on the sub touch panel 118 (step S22).
  • step S24 initial setting and test injection are performed (step S25 ⁇ ).
  • the computer unit 120 acquires electrical resistance as an electrical signal from the load cell 142 without operating the ultrasonic motor 143 of the physiological saline injection mechanism 130P and the design injection mechanism 130C (step S25).
  • the initial setting is executed assuming that the electric resistance indicates a pressure of “0” V (step S26).
  • the computer unit 120 executes test injection by operating the ultrasonic motor 143 only for the physiological saline injection mechanism 130P corresponding to the reference graph (step S27).
  • the screw shaft 137 connected by the ultrasonic motor 143 and the belt mechanism 144 is rotationally driven.
  • the screw shaft 137 is driven by the load cell 142 fixed to the head body 113. Since it is supported in the axial direction through the thrust bearing 139, the slide rod 131 connected to the screw shaft 137 by the screw mechanism is slid. Accordingly, the piston member 220 is pushed into the cylinder member 210 by the slide rod 131, and the chemical solution is injected from the cylinder member 210 to the subject.
  • the pressure acting on the slide rod 131 that presses the piston member 220 also acts on the screw shaft 137, so that the pressure acting on the screw shaft 137 acts on the load cell 142 via the thrust bearing 139.
  • the computer unit 120 obtains the pressure detected by the load cell 142 during the execution of the chemical solution injection as described above (step S28), and the initial value of the chemical solution set by the syringe selection is obtained.
  • the viscosity corresponds to the inner diameter of the cylinder member 210 and the like, and the pushing pressure of the piston member 220 is converted into the chemical injection pressure (step S29).
  • the operator can easily confirm the injection pressure of the chemical solution that does not need to analogize the injection pressure of the chemical solution from the pressure acting on the piston member 220. it can.
  • the various data necessary to convert the pressure of the piston member 220 into the injection pressure of the chemical solution is set just by selecting and operating the chemical syringe 200 listed as described above (Step S8, S9), no complicated data input is required for the operator.
  • this injection pressure force time graph is generated in real time and displayed on the sub-touch panel 118 (step S30), the operator can actually carry out the chemical solution injected in the test. It can be easily confirmed in real time whether the injection pressure of the gas corresponds to the reference graph.
  • the upper limit pressure of the test injection is also set by default corresponding to the imaging site and the chemical syringe 200, so that the injection pressure is increased during the test injection. Whether or not the upper limit pressure is exceeded is constantly monitored (step S31). If the injection pressure exceeds the upper limit pressure, an abnormality is output from the main touch panel 104 and sub touch panel 118 display and the audio output of the speaker unit 105 (step S35), and the physiological saline injection mechanism 130P is activated. Is forcibly stopped (step S36). For this reason, the operator can quickly and reliably recognize that an abnormal pressure has occurred in the test injection, and automatically prevent the test injection from continuing while the abnormal pressure is generated.
  • the chemical injection device 100 of the present embodiment corresponds to the physiological saline injection mechanism corresponding to the reference graph. Since the test injection is executed by driving 130P, if the test injection is executed normally, the shape of the graph over time is similar to the shape of the reference graph. Therefore, for example, the computer unit 120 compares the shape of the graph over time with the shape of the reference graph in real time using the existing image recognition technology (step S32), and an abnormality occurs when the shapes of both graphs are similar. Is detected.
  • the time-lapse graph rapidly decreases in a short time.
  • the time graph is originally higher than the reference graph, the occurrence of an abnormality may not be detected from the difference from the pressure of the reference graph even if the pressure of the time graph decreases.
  • the occurrence of an abnormality is detected if the shape of the reference graph and the shape of the time-dependent graph are not similar, and thus the occurrence of an abnormality is detected even if the pressure difference is not sufficient as described above can do.
  • a sufficient pressure difference is generated between the reference graph and the time-lapse graph, it is determined that the shapes are not similar, and thus an abnormality is detected.
  • a recognition technique used in OCR (Optical Character Reader) or the like can be used as a technique for determining the similarity in shape between the reference graph and the time-dependent graph.
  • test injection pressure can also be adjusted in real time (step S27). Since the manually operated time graph is not compared with the reference graph (step S33), the test injection may be performed in a state where the time graph is not similar to the reference graph according to the operator's request. it can.
  • the time-lapse dull is displayed in real time together with the reference graph as described above, so that the occurrence of abnormality is determined by the operator's judgment on the sub touch panel. It is also possible to perform an input operation on the button 118 (step S34). Even in that case, since the operation of the physiological saline injection mechanism 130P is forcibly stopped (step S36), the time graph determined to be abnormal by the operator is not registered as the reference graph.
  • step S36 when the test injection is interrupted due to the occurrence of an abnormality (step S36), as shown in FIG. 11, the state force operation with the selected imaging region can be resumed. (Step S6) The test injection can be resumed quickly without the need for unnecessary input operations.
  • step S37 the above-described test injection operation is repeated (steps S27 to S37) until the completion of the injection is detected for the force such as the working distance of the physiological saline injection mechanism 130P (step S37).
  • step S37 the operation of the physiological saline injection mechanism 130P is stopped (step S38).
  • a guidance message such as “Do you want to register this injection graph as a reference graph for the next and subsequent times? YZN” is displayed with the reference graph and time graph displayed. Is done. Therefore, when the operator determines that the time graph of the current test injection is registered more appropriately than the current reference graph, the operator manually operates “Y” (step S39).
  • step S40 since the current time graph is registered as the reference graph (step S40), the time graph in which the next force is also registered can be used as the reference graph (steps S20 to S23). Therefore, a time-lapse graph that has been confirmed to be similar to the current reference graph without exceeding the upper limit pressure (steps S31 and S33) can be registered as a new reference graph as desired by the operator (step S40). ).
  • Step S32 Even when a time graph that is not similar to the reference graph is generated manually by the operator (step S32), the time graph can be registered as a new reference graph as desired by the operator. (Step S40). In particular, even if the test injection is manually operated as desired by the operator, the injection pressure is limited to a range that does not exceed the upper limit pressure (step S31), so the test injection is executed at an abnormal pressure. (Step S 36) Dangerous time graphs may not be registered as reference graphs! /.
  • the time-lapse graph registered as the reference graph is registered corresponding to the imaging region and the chemical syringe 200, and if the imaging region and the chemical syringe 200 are selected and operated as described above (Steps S1 to S8). ), The corresponding reference graph is automatically read out (steps S20 to S23), so that the reference graph corresponding to the imaging region and the drug solution syringe 200 can be easily registered and read out.
  • step S41 to S41 the chemical injection device 100 of the present embodiment is in a state in which formal injection can be executed.
  • the operator also moves the vicinity force of the injection head 110 to the vicinity of the injection control unit 101, and inputs a start operation of formal injection to the main touch panel 104.
  • the chemical injection device 100 that has detected this step S41) transmits a work start to the MRI apparatus 300 (step S44).
  • the MRI apparatus 300 that has received the work start from the chemical injection device 100 in this way (step T2) returns the work start to the chemical injection device 100 and executes the imaging operation ( Step ⁇ 8). For this reason, in the chemical injection system 1000 of this embodiment, the imaging of the MRI apparatus 300 follows the chemical injection of the chemical injection apparatus 100.
  • the chemical injection device 100 is in a state where preparation for normal injection is completed (steps S41 to S43), and as shown in FIG.
  • the start of imaging is input (step Tl)
  • the MRI 300 The liquid injection of the liquid injection device 100 follows (steps T4, T6 ⁇ , S42, S47 ⁇ ).
  • step S48 when the chemical injection device 100 performs a series of chemical injection operations (from step S48), the injection start force is also measured for the elapsed time (step S48), and the elapsed time
  • step S49 The contrast medium injection mechanism 130C and the physiological saline injection mechanism 130P are sequentially controlled in real time in accordance with the read injection conditions (step S49).
  • the computer unit 120 obtains the pressure detected by the load cell 142 (step S50), and injects the piston pressure corresponding to the initial viscosity of the chemical solution corresponding to the inner diameter of the cylinder member 210, etc. (Step S51) and confirms that this injection pressure is normal (step S52).
  • the chemical injection device 100 and the MRI device 300 of the present embodiment detect the occurrence of abnormality in the above-mentioned ready state (steps S43, T3), or detect the occurrence of abnormality during operation execution. (Steps S52 and T9), the occurrence of the abnormality is output (Steps S55 and T16), and the operation is stopped (Steps S58 and T18).
  • Steps S54, T15 since the occurrence of the abnormality is also transmitted to the other side (Steps S54, T15), the other side that has received this (Steps T10, S44) also outputs an abnormality occurrence (Steps T16, S46). Also, since one operation stop is also sent to the other (steps S56, T17), the other operation that received this (steps T13, S53) executes the operation stop (steps T18, S57).
  • step S58, Tl l Even when an operation stop is input to one side (step S58, Tl l), the operation stop is executed (step S57, T18) and also sent to the other (step S56). ⁇ ) 17) Even if the other side receives this (step T13, S60), the operation is stopped (step T18, S57) 0
  • step S61 and T14 When the operation completion is detected on one side (steps S61 and T14), the operation end is executed (steps S62 and T19), and the operation end is transmitted to the other side (steps 61). flop S63, T20), the other at even (step Tl 2 which has received this, S59), stops the operation (step T18, S57) 0
  • the drug solution injection of the drug solution injection device 100 and the imaging of the MRI device 300 are automatically linked, so that the contrast agent and the physiological saline are separated. It is possible to take a fluoroscopic image of a subject who is injected in order at an appropriate timing at an appropriate timing.
  • the piston drive mechanism 130 is supported by the head main body 113 so as to be displaceable, and the port cell 142 for detecting the pressure acting on the piston drive mechanism 130 is the head main body 113. It is fixed to. For this reason, since the load cell 142 is arranged in the movable part of the piston drive mechanism 130, the structure is simple and the productivity and reliability are good.
  • the present invention is not limited to the above embodiment, and various modifications are allowed without departing from the scope of the present invention.
  • the chemical injection device 100 having the contrast medium injection mechanism 130C and the physiological saline injection mechanism 130P is exemplified to inject the contrast medium and the physiological saline.
  • a chemical solution injection device (not shown) for injecting only the agent can also be implemented.
  • the chemical injection device 100 having the contrast medium injection mechanism 130C and the physiological saline injection mechanism 130P performs the test injection with the physiological saline.
  • a test injection with a contrast agent.
  • the control data of the piston drive mechanism 130 specialized for confirming the time required for the contrast medium to reach the affected part where the fluoroscopic image is taken is registered in the computer unit 120 as various data of the test injection.
  • the operation of the piston drive mechanism 130 can be controlled in accordance with the control data.
  • the main touch panel 104 and the sub touch panel 118 execute the input operation and display of formal injection and test injection.
  • the chemical injection device 100 is connected online to the host computer of the manufacturer of the chemical syringe 200, and various data are online to the chemical injection device 100 each time a new chemical syringe 200 is shipped. It is also possible to provide it with (not shown).
  • the pressure of the piston member 220 is converted into the injection pressure of the chemical liquid based on various data of the chemical liquid syringe 200.
  • a load cell inside the cylinder member 210 or the extension tube 230 (not shown), it is possible to directly detect the injection pressure of the chemical solution.
  • At least one chemical syringe 200 is registered for each imaging region, and when there are a plurality of registered chemical syringes 200, a list is displayed and an operator performs a selection operation. did. However, only one chemical syringe 200 is registered for each imaging region, and syringe data can be automatically read when an imaging region is selected.
  • the MRI apparatus 300 is used as the fluoroscopic imaging apparatus, and the liquid injector 100 injects the MR contrast agent.
  • a CT scanner or PET device is used as a fluoroscopic imaging device, and a contrast medium for that is injected by a chemical injection device. Is also possible.
  • each of these various means can be formed as unique hardware, and a part thereof can be stored as software in the RAM 123 or the like and a part can be formed as nodeware.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Graph creating means (152) creates an injection pressure to be detected during the execution of a test injection, as an aging graph in real time. A reference graph corresponding to the injection pressure at the time when the test injection is properly executed is stored in graph storage means (153). The shape of the reference graph and the shape of the aging graph are compared in real time by graph comparing means (156). If the shapes of the two are not similar, an anomaly occurrence is detected by anomaly detecting means (157).

Description

明 細 書  Specification
薬液注入装置  Chemical injection device
技術分野  Technical field
[0001] 本発明は、被験者に薬液を注入する薬液注入装置に関し、特に、 CT(Computed T omography)スキャナや MRI(Magnetic  [0001] The present invention relates to a chemical injection device for injecting a chemical into a subject, and in particular, a CT (Computed Tomography) scanner or an MRI (Magnetic Magnetic).
Resonance Imagingノ装 や PET(Positron Emission Tomography)装 などの; ¾ jajfe 像装置で透視画像が撮像される被験者に造影剤を注入する薬液注入装置に関する 背景技術  Resonance Imaging equipment, PET (Positron Emission Tomography) equipment, etc .; ¾ Background technology related to chemical injection equipment that injects a contrast medium into a subject whose fluoroscopic images are taken with a jajfe imaging device
[0002] 現在、被験者の透視画像を撮像する透視撮像装置としては、 CTスキャナ、 MRI装 置、 PET装置、超音波診断装置、 CTアンギオ装置、 MRアンギオ装置、等がある。 上述のような装置を使用するとき、被験者に造影剤や生理食塩水などの薬液を注入 することがあり、この注入を自動的に実行する薬液注入装置も実用化されている。  [0002] Currently, there are CT scanners, MRI apparatuses, PET apparatuses, ultrasonic diagnostic apparatuses, CT angio apparatuses, MR angio apparatuses, and the like as fluoroscopic imaging apparatuses that capture a fluoroscopic image of a subject. When using the above-described device, a chemical solution such as a contrast medium or physiological saline may be injected into the subject, and a chemical solution injection device that automatically executes this injection has also been put into practical use.
[0003] このような薬液注入装置は、例えば、駆動モータゃスライダ機構などを備えたピスト ン駆動機構を有しており、薬液シリンジが着脱自在に装着される。薬液シリンジは、シ リンダ部材と、スライダ部材にスライド自在に挿入されて 、るピストン部材とを有して ヽ る。造影剤や生理食塩水などの薬液はシリンダ部材に充填されて 、る。  [0003] Such a chemical solution injection device has, for example, a piston drive mechanism including a drive motor and a slider mechanism, and a chemical solution syringe is detachably attached thereto. The chemical syringe includes a cylinder member and a piston member that is slidably inserted into the slider member. The cylinder member is filled with a chemical solution such as contrast medium or physiological saline.
[0004] このような薬液シリンジを延長チューブで被験者に連結してピストン駆動機構に装 着すると、薬液注入装置は、ピストン駆動機構でピストン部材にシリンダ部材を押し込 み、これによつて薬液シリンジカゝら被験者に造影剤が注入される。その場合、作業者 が各種条件を考慮して造影剤の注入速度や注入容量などを決定し、それを薬液注 入装置に数値入力すると、この薬液注入装置は入力数値に対応して造影剤を被験 者に注入する。この造影剤の注入により被験者の造影度が変化するので、透視撮像 装置により良好な透視画像が撮像されることになる。  [0004] When such a chemical syringe is connected to a subject with an extension tube and attached to the piston drive mechanism, the chemical injection device pushes the cylinder member into the piston member by the piston drive mechanism, thereby using the chemical syringe syringe. A contrast medium is injected into the subject. In that case, when the operator determines the injection speed and injection volume of the contrast medium in consideration of various conditions, and inputs these values to the liquid injection device, the liquid injection apparatus applies the contrast medium according to the input numerical values. Inject the subject. Since the contrast level of the subject changes due to the injection of the contrast agent, a good fluoroscopic image is taken by the fluoroscopic imaging device.
[0005] なお、薬液注入装置には造影剤とともに生理食塩水も被験者に注入できる製品が ある。このような薬液注入装置には、造影剤が充填されている造影剤シリンジおよび 生理食塩水が充填されている生理食塩水シリンジが薬液シリンジとして並列に装着さ れる。造影剤シリンジと生理食塩水シリンジとは、通常は二股の 1個の延長チューブ で被験者に連結される。 [0005] It should be noted that there are products that can inject physiological saline into a subject together with a contrast medium in a chemical solution injector. In such a chemical solution injection device, a contrast agent syringe filled with a contrast agent and a physiological saline syringe filled with physiological saline are mounted in parallel as a chemical solution syringe. It is. The contrast syringe and the saline syringe are usually connected to the subject by a single bifurcated extension tube.
[0006] そして、作業者が所望により造影剤の注入完了に連動して生理食塩水を注入する ことを注入速度や注入容量などとともに薬液注入装置にデータ入力すると、薬液注 入装置は、入力データに対応して被験者に造影剤を注入してから自動的に生理食 塩水も注入する。このため、造影剤を生理食塩水で後押しして造影剤の消費量を削 減することや、生理食塩水によりアーチファクトを軽減することができる。  [0006] Then, when the operator inputs data to the chemical solution injection device together with the injection speed, the injection volume, and the like to inject physiological saline in conjunction with the completion of the injection of the contrast agent as desired, the chemical solution injection device receives the input data. Corresponding to the above, a contrast medium is injected into the subject and then physiological saline is also injected automatically. For this reason, the contrast agent can be boosted with physiological saline to reduce the consumption of the contrast agent, and the artifact can be reduced with the physiological saline.
[0007] また、上述のような薬液注入装置で薬液シリンジ力 被験者まで延長チューブで薬 液を注入する場合、通常は最初に延長チューブの連結状態を確認するために試験 注入を実行する。この試験注入では、正式注入より高圧で微量の薬液が注入され、 作業者により異常の有無が判断される。  [0007] In addition, when a chemical solution is injected to an examinee with an extension tube using the above-described chemical solution injection device as described above, a test injection is usually performed first to confirm the connection state of the extension tube. In this test injection, a small amount of chemical solution is injected at a higher pressure than the official injection, and the operator determines whether there is an abnormality.
[0008] 例えば、試験注入の最中に延長チューブが被験者力 外れると、検出される圧力 が急激に低下する。また、試験注入の最中に延長チューブが途中で折れ曲がると、 検出される圧力が急激に上昇する。薬液注入装置は試験注入する薬液の圧力をリア ルタイムに表示するので、作業者は圧力を監視することで異常発生を判断することが できる。  [0008] For example, if the extension tube is removed from the subject force during the test injection, the detected pressure rapidly decreases. Also, if the extension tube bends during the test injection, the detected pressure rises rapidly. Since the chemical injection device displays the pressure of the chemical to be injected in real time, the operator can judge the occurrence of abnormality by monitoring the pressure.
[0009] 上述のように延長チューブの連結状態を確認する試験注入は、造影剤シリンジの み装着される薬液注入装置では造影剤の注入により実行され、造影剤シリンジと生 理食塩水シリンジとが装着される薬液注入装置では、コストの観点力 通常は生理食 塩水の注入により実行される。  [0009] As described above, the test injection for confirming the connection state of the extension tube is performed by injection of a contrast medium in a chemical liquid injection apparatus in which only a contrast medium syringe is mounted, and the contrast medium syringe and the physiological saline syringe are connected. In terms of cost, the chemical injection device is usually implemented by injection of physiological saline.
[0010] さらに、正式注入に先行して実行される試験注入としては、造影剤が患部まで到達 する所要時間を確認するための試験注入も実行されている。この試験注入では、正 式注入と同一の速度で造影剤が注入され、その注入開始から患部に造影剤が到達 するまでの所要時間が計測される。  [0010] Further, as test injection executed prior to formal injection, test injection for confirming the time required for the contrast medium to reach the affected area is also executed. In this test injection, contrast medium is injected at the same rate as normal injection, and the time required from the start of injection until the contrast medium reaches the affected area is measured.
[0011] また、現在の一般的な薬液注入装置では、薬液シリンジが装着される注入ヘッドと [0011] Further, in the current general chemical solution injection device, an injection head to which a chemical solution syringe is attached;
、表示や入力操作が実行される注入制御ユニットとは、別体に構成されている。この ため、被験者の近傍に注入ヘッドを自在に配置することができ、透視撮像装置の撮 像制御装置の近傍などに注入制御ユニットを配置することができる。 [0012] 特に、透視撮像装置が MRI装置の場合、マイクロコンピュータを内蔵して ヽる注入 制御ユニットは MRI装置の透視撮像ユニットの近傍には配置できな 、ので、上述の ように注入ヘッドと注入制御ユニットとを別々に配置できる構造は有用である。 The injection control unit in which display and input operations are executed is configured separately. Therefore, the injection head can be freely arranged in the vicinity of the subject, and the injection control unit can be arranged in the vicinity of the imaging control device of the fluoroscopic imaging device. [0012] In particular, when the fluoroscopic imaging apparatus is an MRI apparatus, the injection control unit with a built-in microcomputer cannot be arranged in the vicinity of the fluoroscopic imaging unit of the MRI apparatus. A structure that can be arranged separately from the control unit is useful.
[0013] なお、本出願人は、上述のように注入ヘッドと注入制御ユニットとが別体の構造で、 試験注入の入力操作と表示を注入ヘッドで実行するとともに、正式注入の入力操作 と表示を注入制御ユニットで実行することにより、試験注入と正式注入との作業性を 向上させた薬液注入装置を発明して出願している (例えば、特許文献 1参照)。  [0013] It should be noted that, as described above, the present applicant has a structure in which the injection head and the injection control unit are separated, and the test injection input operation and display are executed by the injection head, and the formal injection input operation and display are performed. Has been filed by inventing a chemical solution injection device that improves the workability of test injection and formal injection by executing the injection control unit (see, for example, Patent Document 1).
特許文献 1:特願 2003 - 368859号 (WO2005/039675A1)  Patent Document 1: Japanese Patent Application No. 2003-368859 (WO2005 / 039675A1)
上述のような薬液注入装置は、試験注入する薬液の圧力をリアルタイムに表示する ので、作業者は、その圧力を監視することにより異常の有無を判断することができる。 しかし、換言すると薬液注入装置が表示する圧力を作業者が監視していないと異常 発生が判定されないことになり、作業者の負担が大きいとともに異常発生の発見が遅 滞する可能性もある。  Since the chemical injection device as described above displays the pressure of the chemical to be injected in real time, the operator can determine whether there is an abnormality by monitoring the pressure. However, in other words, if the operator does not monitor the pressure displayed by the chemical injection device, the occurrence of an abnormality will not be determined, and the burden on the operator is heavy and the detection of the occurrence of the abnormality may be delayed.
[0014] 例えば、試験注入の圧力に対して所定の許容範囲を薬液注入装置に設定してお き、検出する圧力が許容範囲を逸脱したときに薬液注入装置が異常発生を検出する ことが想定できる。しかし、検出される圧力が許容範囲を満足しながらも急激に変化 したときなどは確認が必要である力 上述のような薬液注入装置では、圧力が急激に 変化しても許容範囲が満足されているならば異常発生は検出されない。  [0014] For example, it is assumed that a predetermined allowable range is set for the chemical injection device with respect to the test injection pressure, and the chemical injection device detects an abnormality when the detected pressure deviates from the allowable range. it can. However, the force that needs to be confirmed when the detected pressure changes suddenly while satisfying the allowable range, etc. With the chemical injection device as described above, the allowable range is satisfied even if the pressure changes suddenly. If so, the occurrence of an abnormality is not detected.
[0015] また、経時的に変化する圧力で試験注入を実行することが医療現場で要望される こともある。この場合は、例えば、圧力の変化パターンが医療現場で薬液注入装置に 設定される。すると、薬液注入装置に設定されている許容範囲が試験注入で検出さ れる圧力に対応しないことになり、異常発生を有効に検出できない状態などとなる。 発明の開示  [0015] In addition, it may be desired in the medical field to perform a test injection at a pressure that changes over time. In this case, for example, a pressure change pattern is set in the chemical injection device at the medical site. Then, the allowable range set in the chemical solution injection device does not correspond to the pressure detected by the test injection, and the occurrence of abnormality cannot be effectively detected. Disclosure of the invention
[0016] 本発明は上述のような課題に鑑みてなされたものであり、試験注入の圧力が所定 範囲で急激に変化したような場合や、圧力の変化パターンが変更されたような場合で も、異常発生を良好に検出できる薬液注入装置を提供することを目的とする。  [0016] The present invention has been made in view of the above-described problems, and even when the pressure of the test injection is suddenly changed within a predetermined range or when the change pattern of the pressure is changed. An object of the present invention is to provide a chemical liquid injector capable of detecting abnormal occurrences satisfactorily.
[0017] 本発明の薬液注入装置は、シリンダ部材にピストン部材がスライド自在に挿入され ている薬液シリンジ力 被験者まで延長チューブで薬液を試験注入して力 正式注 入する薬液注入装置であって、ピストン駆動機構、圧力検出手段、グラフ生成手段、 グラフ記憶手段、グラフ比較手段、異常検出手段、警告報知手段、を有している。 [0017] The chemical injection device of the present invention is a chemical liquid syringe force in which a piston member is slidably inserted into a cylinder member. The chemical injection device is a piston drive mechanism, pressure detection means, graph generation means, graph storage means, graph comparison means, abnormality detection means, and warning notification means.
[0018] ピストン駆動機構は、シリンダ部材にピストン部材を押し込む。圧力検出手段は、被 験者に注入される薬液の圧力を検出する。グラフ生成手段は、試験注入の実行中に 検出される圧力を経時グラフとしてリアルタイムに生成する。グラフ記憶手段は、試験 注入が適正に実行されたときの圧力に相当する基準グラフを記憶している。グラフ比 較手段は、経時グラフの形状を基準グラフの形状とリアルタイムに比較する。異常検 出手段は、経時グラフの形状と基準グラフの形状とが類似しないと異常発生を検出 する。  [0018] The piston drive mechanism pushes the piston member into the cylinder member. The pressure detection means detects the pressure of the chemical solution injected into the subject. The graph generating means generates the pressure detected during execution of the test injection in real time as a time graph. The graph storage means stores a reference graph corresponding to the pressure when the test injection is properly executed. The graph comparison means compares the shape of the time graph with the shape of the reference graph in real time. The abnormality detection means detects the occurrence of an abnormality if the shape of the time-dependent graph is not similar to the shape of the reference graph.
[0019] 従って、本発明の薬液注入装置では、例えば、既存の画像認識技術により経時グ ラフと基準グラフとが比較され、基準グラフと経時グラフとが類似していないと異常発 生が検出されるので、試験注入の圧力が所定範囲で急激に変化した場合でも、圧力 の変化パターンが変更された場合でも、異常発生が検出される。  Therefore, in the chemical injection device of the present invention, for example, the time-lapse graph and the reference graph are compared by the existing image recognition technology, and if the reference graph and the time-lapse graph are not similar, the occurrence of abnormality is detected. Therefore, the occurrence of an abnormality is detected even when the pressure of the test injection changes rapidly within a predetermined range or when the pressure change pattern is changed.
[0020] なお、本発明で云う各種手段は、その機能を実現するように形成されて!、れば良く 、例えば、所定の機能を発揮する専用のハードウェア、所定の機能がコンピュータプ ログラムにより付与されたデータ処理装置、コンピュータプログラムによりデータ処理 装置に実現された所定の機能、これらの組み合わせ、等として実現することができる  [0020] It should be noted that the various means referred to in the present invention may be formed so as to realize their functions! For example, dedicated hardware that exhibits a predetermined function, and a predetermined function provided by a computer program. Can be realized as a predetermined function implemented in the data processing apparatus by a computer program, a combination thereof, etc.
[0021] また、本発明で云う各種の構成要素は、かならずしも個々に独立した存在である必 要はなぐ複数の構成要素が 1個の部材として形成されていること、 1つの構成要素 が複数の部材で形成されて 、ること、ある構成要素が他の構成要素の一部であること 、ある構成要素の一部と他の構成要素の一部とが重複していること、等も可能である 図面の簡単な説明 [0021] In addition, the various constituent elements referred to in the present invention are not necessarily required to be individually independent, but a plurality of constituent elements are formed as one member, and one constituent element includes a plurality of constituent elements. It is possible to be formed of members, a certain component is a part of another component, a part of a certain component overlaps a part of another component, etc. Brief description of the drawings
[0022] [図 1]本発明の一実施形態による薬液注入装置の論理構造を示す模式図である。  FIG. 1 is a schematic diagram showing a logical structure of a chemical liquid injector according to an embodiment of the present invention.
[図 2]薬液注入システムの物理構造を示すブロック図である。  FIG. 2 is a block diagram showing a physical structure of a chemical solution injection system.
[図 3]薬液注入システムの外観を示す斜視図である。  FIG. 3 is a perspective view showing an appearance of a chemical liquid injection system.
圆 4]薬液注入装置の外観を示す斜視図である。 圆 5]薬液注入装置の注入ヘッドに薬液シリンジを装着する状態を示す斜視図である 圆 6]注入ヘッドの内部構造を示す模式的な断面図である。 圆 4] It is a perspective view showing the appearance of the chemical liquid injector. 圆 5] A perspective view showing a state in which a chemical syringe is attached to the injection head of the chemical injection device. 圆 6] A schematic cross-sectional view showing the internal structure of the injection head.
[図 7]サブ操作パネルとサブディスプレイパネルとを兼用したサブタツチパネルの表示 画面の一例を示す図である。  FIG. 7 is a diagram showing an example of a display screen of a sub touch panel that serves as both a sub operation panel and a sub display panel.
[図 8]メイン操作パネルとメインディスプレイパネルとを兼用したメインタツチパネルに 身体区分の模式画像と白紙状態の条件画面とが表示された状態を示す図である。 圆 9]身体区分が選定された状態のメインタツチパネルの表示画面を示す図である。 圆 10]撮像部位が選定されて条件画像が表示された状態のメインタツチパネルの表 示画面を示す図である。  FIG. 8 is a diagram showing a state in which a schematic image of a body section and a blank condition screen are displayed on a main touch panel that serves as both a main operation panel and a main display panel. [9] FIG. 9 is a diagram showing a display screen of the main touch panel in a state where the body classification is selected. [10] FIG. 10 is a diagram showing a display screen of the main touch panel in a state in which an imaging region is selected and a condition image is displayed.
[図 11]薬液注入装置の処理動作の序盤部分を示すフローチャートである。  FIG. 11 is a flowchart showing an early part of the processing operation of the chemical injection device.
[図 12]薬液注入装置の処理動作の中盤部分を示すフローチャートである。 FIG. 12 is a flowchart showing the middle part of the processing operation of the chemical injection device.
[図 13]薬液注入装置の処理動作の終盤部分を示すフローチャートである。 FIG. 13 is a flowchart showing an end portion of the processing operation of the chemical liquid injector.
[図 14]透視撮像装置である MRI装置の処理動作を示すフローチャートである。 符号の説明 FIG. 14 is a flowchart showing a processing operation of an MRI apparatus which is a fluoroscopic imaging apparatus. Explanation of symbols
100 薬揿注入装置  100 cartridge case injection device
101 注入制御ユニット  101 Injection control unit
103 メイン操作パネル  103 Main operation panel
104 メインタツチパネル  104 Main touch panel
110 注入ヘッド  110 injection head
118 サブタツチパネル  118 Sub-touch panel
120 コンピュータユニット  120 computer units
130 ピストン駆動機構  130 Piston drive mechanism
151 圧力検出手段  151 Pressure detection means
152 グラフ生成手段  152 Graph generation means
153 グラフ記憶手段  153 Graph storage means
156 グラフ比較手段  156 Graph comparison means
157 異常検出手段 158 警告報知手段 157 Anomaly detection means 158 Warning notification means
159 駆動制御手段  159 Drive control means
161 入力操作手段  161 Input operation means
162 グラフ登録手段  162 Graph registration means
200 薬液シリンジ  200 chemical syringe
210 シリンダ部材  210 Cylinder member
220 ピストン部材  220 Piston member
300 MRI装置  300 MRI machine
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0024] [実施の形態の構成]  [Configuration of Embodiment]
本発明の一実施形態による薬液注入システム 1000は、図 1ないし図 3に示すように 、薬液注入装置 100、薬液シリンジ 200、および透視撮像装置である MRI装置 300 を有しており、詳細には後述するが、被験者 (図示せず)に薬液として造影剤などを注 入する。  As shown in FIG. 1 to FIG. 3, a chemical injection system 1000 according to an embodiment of the present invention includes a chemical injection device 100, a chemical syringe 200, and an MRI apparatus 300 that is a fluoroscopic imaging device. As will be described later, a contrast medium or the like is injected into the subject (not shown) as a drug solution.
[0025] MRI装置 300は、図 3に示すように、透視撮像ユニット 301と撮像制御ユニット 302 とを有している。透視撮像ユニット 301と撮像制御ユニット 302とは通信ネットワーク 3 03で有線接続されて 、る。透視撮像ユニット 301は被験者から透視画像を撮像し、 撮像制御ユニット 302は透視撮像ユニット 301の動作を制御する。  As shown in FIG. 3, the MRI apparatus 300 includes a fluoroscopic imaging unit 301 and an imaging control unit 302. The fluoroscopic imaging unit 301 and the imaging control unit 302 are connected to each other through a communication network 303. The fluoroscopic imaging unit 301 captures a fluoroscopic image from the subject, and the imaging control unit 302 controls the operation of the fluoroscopic imaging unit 301.
[0026] 薬液シリンジ 200は、図 5に示すように、シリンダ部材 210とピストン部材 220とを有 している。ピストン部材 220はシリンダ部材 210にスライド自在に挿入されている。シリ ンダ部材 210は、円筒形の本体部 211を有しており、この本体部 211の閉塞した先 端面に導管部 212が形成されている。  [0026] The chemical syringe 200 has a cylinder member 210 and a piston member 220 as shown in FIG. The piston member 220 is slidably inserted into the cylinder member 210. The cylinder member 210 has a cylindrical main body 211, and a conduit 212 is formed on the closed end face of the main body 211.
[0027] シリンダ部材 210の本体部 211の末端面は開口されており、この開口から本体部 2 11の内部にピストン部材 220が挿入されて 、る。シリンダ部材 210の末端外周には シリンダフランジ 213が形成されており、ピストン部材 220の末端外周にはピストンフ ランジ 221が形成されている。  The end face of the main body 211 of the cylinder member 210 is opened, and the piston member 220 is inserted into the main body 211 from this opening. A cylinder flange 213 is formed on the outer periphery of the cylinder member 210, and a piston flange 221 is formed on the outer periphery of the piston member 220.
[0028] 本形態の薬液注入装置 100は、図 4に示すように、注入制御ユニット 101と、注入 制御ユニット 101と別体に構成された注入装置本体である注入ヘッド 110とを有して いる。注入制御ユニット 101と注入ヘッド 110とは通信ケーブル 102で有線接続され ている。注入ヘッド 110は、装着される薬液シリンジ 200を駆動して被験者に薬液を 注入する。注入制御ユニット 101は、注入ヘッド 110の動作を制御する。 [0028] As shown in FIG. 4, the chemical injection device 100 of the present embodiment includes an injection control unit 101, and an injection head 110 that is an injection device body configured separately from the injection control unit 101. Yes. Injection control unit 101 and injection head 110 are wire-connected with communication cable 102. The injection head 110 drives the chemical solution syringe 200 to be attached to inject the chemical solution into the subject. The injection control unit 101 controls the operation of the injection head 110.
[0029] このため、図 2に示すように、注入制御ユニット 101にはコンピュータユニット 120が 内蔵されている。コンピュータユニット 120は、 MRI装置 300の撮像制御ユニット 302 とも通信ネットワーク 304で有線接続されて ヽる。  For this reason, as shown in FIG. 2, the injection control unit 101 has a computer unit 120 built therein. The computer unit 120 is also connected to the imaging control unit 302 of the MRI apparatus 300 through a communication network 304 by wire.
[0030] 注入制御ユニット 101は、図 4に示すように、メイン操作パネル 103、操作部とメイン ディスプレイパネルとを兼用したメインタツチパネル 104、スピーカユニット 105、等が 本体ハウジング 106の前面に配置されており、別体のコントローラユニット 107が接続 ケーブル 108で有線接続されて 、る。  [0030] As shown in Fig. 4, the injection control unit 101 includes a main operation panel 103, a main touch panel 104 that combines the operation unit and the main display panel, a speaker unit 105, and the like arranged on the front surface of the main body housing 106. A separate controller unit 107 is wired with a connection cable 108.
[0031] 注入ヘッド 110は、キャスタスタンド 111の上端に可動アーム 112を介して装着され ている。注入ヘッド 110は、図 5に示すように、ヘッド本体 113を有しており、そのへッ ド本体 113の上面には、薬液シリンジ 200を保持する半円筒形の溝状の凹部 114が 形成されている。  The injection head 110 is attached to the upper end of the caster stand 111 via the movable arm 112. As shown in FIG. 5, the injection head 110 has a head main body 113, and a semicylindrical groove-shaped concave portion 114 that holds the chemical syringe 200 is formed on the upper surface of the head main body 113. ing.
[0032] 凹部 114の前部には、薬液シリンジ 200のシリンダフランジ 213を保持するシリンダ 保持機構 116が形成されている。凹部 114の後方には、ピストンフランジ 221を保持 してスライドさせるピストン駆動機構 130が配置されている。シリンダ保持機構 116は 、凹部 114の内面に形成された凹溝を有しており、この凹溝にシリンダフランジ 213 が係合する。  A cylinder holding mechanism 116 that holds the cylinder flange 213 of the chemical liquid syringe 200 is formed in the front part of the recess 114. A piston drive mechanism 130 that holds and slides the piston flange 221 is disposed behind the recess 114. The cylinder holding mechanism 116 has a concave groove formed in the inner surface of the concave portion 114, and the cylinder flange 213 is engaged with the concave groove.
[0033] 注入ヘッド 110の 2つの凹部 114には、薬液として造影剤が充填されている造影剤 シリンジ 200Cと、薬液として生理食塩水が充填されて!、る生理食塩水シリンジ 200P と、が個々に装着される。ピストン駆動機構 130は各凹部 114に対応して配置されて いる。これら 2つの凹部 114と 2個のピストン駆動機構 130により、被験者に造影剤を 注入する造影剤注入機構 130Cと生理食塩水を注入する生理食塩水注入機構 130 Pとが構成されている。  [0033] The two concave portions 114 of the injection head 110 are individually provided with a contrast medium syringe 200C filled with a contrast medium as a chemical solution and a physiological saline syringe 200P filled with a physiological saline solution as a chemical liquid! It is attached to. The piston drive mechanism 130 is disposed corresponding to each recess 114. The two recesses 114 and the two piston drive mechanisms 130 constitute a contrast medium injection mechanism 130C for injecting a contrast medium into a subject and a physiological saline injection mechanism 130P for injecting physiological saline.
[0034] ピストン駆動機構 130は、図 6に示すように、スライダ部材として前後方向に細長い スライドロッド 131を有して 、る。このスライドロッド 131が軸心を中心に回転不能な状 態で前後方向にスライド自在にヘッド本体 113に支持されて 、る。 [0035] スライドロッド 131の前端にはピストン押圧部材 132がー体に形成されている。ピスト ン押圧部材 132には、一対の係合爪 133が弹発的に開閉自在に装着されている。ス ライドロッド 131には、その後面中央力も前方に向力つてネジ穴 134が形成されてい る。このネジ穴 134に係合する雄ネジ 136が、回転部材であるスクリューシャフト 137 に形成されている。 As shown in FIG. 6, the piston drive mechanism 130 has a slide rod 131 that is elongated in the front-rear direction as a slider member. The slide rod 131 is supported by the head body 113 so as to be slidable in the front-rear direction in a state in which the slide rod 131 cannot rotate about the axis. A piston pressing member 132 is formed in the body at the front end of the slide rod 131. A pair of engaging claws 133 are attached to the piston pressing member 132 so as to be freely opened and closed. A threaded hole 134 is formed in the slide rod 131 such that the center force on the rear surface is also directed forward. A male screw 136 that engages with the screw hole 134 is formed on a screw shaft 137 that is a rotating member.
[0036] スクリューシャフト 137は、ヘッド本体 113にラジアル軸受 138により回転自在に支 持されており、スラスト軸受 139により回転自在な状態で軸心方向に支持されている 。より詳細には、スクリューシャフト 137の後端近傍には円環状のフランジ部 141が形 成されており、このフランジ部 141の後面に円環状のスラスト軸受 139が当接している  The screw shaft 137 is rotatably supported on the head body 113 by a radial bearing 138, and is supported by the thrust bearing 139 in the axial direction in a rotatable state. More specifically, an annular flange portion 141 is formed near the rear end of the screw shaft 137, and an annular thrust bearing 139 is in contact with the rear surface of the flange portion 141.
[0037] スラスト軸受 139の後面には同一形状のロードセル 142が圧力検出素子として当接 している。ロードセル 142はヘッド本体 113に固定されている力 スラスト軸受 139は ヘッド本体 113に前後方向に微少に変位できる状態に支持されて 、る。 A load cell 142 having the same shape is in contact with the rear surface of the thrust bearing 139 as a pressure detection element. The load cell 142 is a force fixed to the head main body 113. The thrust bearing 139 is supported by the head main body 113 so as to be slightly displaceable in the front-rear direction.
[0038] ピストン駆動機構 130は、図 2に示すように、駆動モータとして超音波モータ 143を 有しており、この超音波モータ 143が、図 6に示すように、ベルト機構 144でスクリュー シャフト 137に連結されている。より詳細には、スクリューシャフト 137の後端にはベル ト車 145がー体に装着されており、超音波モータ 143のロータ部材にもベルト車が一 体に装着されており (図示せず)、これらのベルト車 145にエンドレスベルト 146が張架 されている。  As shown in FIG. 2, the piston drive mechanism 130 has an ultrasonic motor 143 as a drive motor, and the ultrasonic motor 143 includes a belt mechanism 144 and a screw shaft 137 as shown in FIG. It is connected to. More specifically, a belt wheel 145 is attached to the rear end of the screw shaft 137, and a belt wheel is also attached to the rotor member of the ultrasonic motor 143 (not shown). An endless belt 146 is stretched around these belt wheels 145.
[0039] 本形態では、注入ヘッド 110は、各部が非磁性体で形成されており、非磁性体で形 成できない部分は防磁されている。例えば、超音波モータ 143は、作動時にも磁界を 発生しないように、燐青銅合金 (Cu+Sn+P)、チタン合金 (Ή-6Α卜 4V)、マグネシウム合 金 (Mg+Al+Zn)、などの非磁性体の金属で形成されている。ロードセル 142ゃスクリュ 一シャフト 137なども同様に非磁性体の金属で形成されている。ベルト機構 144やへ ッド本体 113などは非磁性体の榭脂で形成されて 、る。  [0039] In this embodiment, each part of the injection head 110 is formed of a nonmagnetic material, and a portion that cannot be formed of a nonmagnetic material is shielded. For example, the ultrasonic motor 143 has phosphor bronze alloy (Cu + Sn + P), titanium alloy (Ή-6Α 卜 4V), magnesium alloy (Mg + Al + Zn), It is made of non-magnetic metal such as. Similarly, the load cell 142, the screw, the shaft 137, etc. are made of non-magnetic metal. The belt mechanism 144 and the head body 113 are made of non-magnetic grease.
[0040] 本形態の薬液注入装置 100では、メイン操作パネル 103やロードセル 142などはコ ンピュータユニット 120に接続されており、このコンピュータユニット 120力 実装され ているコンピュータプログラムに対応して各部を統合制御する。このため、注入制御 ユニット 101のメイン操作パネル 103やメインタツチパネル 104やコントローラユニット 107の入力操作に対応してコンピュータユニット 120が注入ヘッド 110のピストン駆動 機構 130の動作を制御し、この制御に関連した各種データをコンピュータユニット 12 0はメインタツチパネル 104に表示させる。 [0040] In the chemical injection device 100 of this embodiment, the main operation panel 103, the load cell 142, and the like are connected to the computer unit 120, and each part is integrated and controlled in accordance with the computer program installed in the computer unit 120 force. To do. Because of this, injection control The computer unit 120 controls the operation of the piston drive mechanism 130 of the injection head 110 in response to input operations of the main operation panel 103, main touch panel 104, and controller unit 107 of the unit 101, and various data related to this control are stored in the computer. The unit 120 is displayed on the main touch panel 104.
[0041] 図 5に示すように、注入ヘッド 110の側部には、サブ操作パネルとサブディスプレイ パネルとを兼用したサブタツチパネル 118が装着されて!、る。このサブタツチパネル 1 18力 の入力操作でもコンピュータユニット 120は注入ヘッド 110のピストン駆動機 構 130の動作を制御し、この制御に関連した各種データをサブタツチパネル 118にも 表示させる。 As shown in FIG. 5, a sub-touch panel 118 serving as both a sub-operation panel and a sub-display panel is attached to the side of the injection head 110! The computer unit 120 also controls the operation of the piston drive mechanism 130 of the injection head 110 and displays various data related to this control on the sub-touch panel 118 even when the sub-touch panel 118 is input.
[0042] ただし、詳細には後述する力 サブタツチパネル 118は、メインタツチパネル 104に 比較して画面サイズが小さくピクセル数も少な 、ので、表示できるデータ量も少量で ある。このため、表示が必要な各種データの全部がメインタツチパネル 104には表示 される力 サブタツチパネル 118には一部のみが表示される。  However, since the force sub-touch panel 118, which will be described in detail later, has a smaller screen size and fewer pixels than the main touch panel 104, the amount of data that can be displayed is small. For this reason, all of the various data that need to be displayed is displayed on the main touch panel 104. Only a part is displayed on the sub touch panel 118.
[0043] 本形態の薬液注入装置 100では、コンピュータユニット 120は、図 2に示すように、 CPU(Central Processing Unit)121、 ROM(Read Only Memory) 122、 RAM(Rando m  In the chemical injection device 100 of this embodiment, as shown in FIG. 2, the computer unit 120 includes a CPU (Central Processing Unit) 121, a ROM (Read Only Memory) 122, a RAM (Rando m
Access Memory) 123, l/F(Interface)124,等のハードウェアを有している。  Access Memory) 123, l / F (Interface) 124, and the like.
[0044] コンピュータユニット 120は、その ROM122などの情報記憶媒体に専用のコンビュ ータプログラムがファームウェアなどで実装されており、そのコンピュータプログラムに 対応して CPU 121が各種の処理動作を実行する。 [0044] In the computer unit 120, a dedicated computer program is mounted on an information storage medium such as the ROM 122 by firmware or the like, and the CPU 121 executes various processing operations corresponding to the computer program.
[0045] コンピュータユニット 120はメインタツチパネル 104およびサブタツチパネル 118から のデータ入力を認識するとともに表示を制御するので、本形態の薬液注入装置 100 では、正式注入の各種データはメインタツチパネル 104で入力操作されるとともにメイ ンタツチパネル 104で表示され、試験注入の各種データはサブタツチパネル 118で 入力操作されるとともにサブタツチパネル 118で表示される。  [0045] Since the computer unit 120 recognizes data input from the main touch panel 104 and the sub touch panel 118 and controls the display, the chemical injection device 100 of this embodiment stores various data of formal injection on the main touch panel 104. The input operation is performed and displayed on the main touch panel 104, and various data of the test injection are input on the sub touch panel 118 and displayed on the sub touch panel 118.
[0046] より具体的には、コンピュータユニット 120は、延長チューブ 230の連結状態の確認 のために特ィ匕されたピストン駆動機構 130の制御データが試験注入の各種データと して登録されており、サブタツチパネル 118に試験注入の開始指令が入力操作され ると、試験注入の制御データに対応して生理食塩水注入機構 130Pの超音波モータ 143の動作を制御する。 [0046] More specifically, in the computer unit 120, the control data of the piston drive mechanism 130 specially designed for confirming the connection state of the extension tube 230 is registered as various types of test injection data. The test touch start command is input to the sub touch panel 118. Then, the operation of the ultrasonic motor 143 of the physiological saline injection mechanism 130P is controlled corresponding to the test injection control data.
[0047] 本形態の薬液注入装置 100は、上述のようにコンピュータユニット 120がコンビユー タプログラムおよび試験注入の制御データに対応して動作することにより、圧力検出 手段 151、グラフ生成手段 152、グラフ記憶手段 153、グラフ表示手段 154、グラフ 比較手段 156、異常検出手段 157、警告報知手段 158、駆動制御手段 159、入力 操作手段 161、およびグラフ登録手段 162等の各種手段を論理的に有して ヽる。 [0047] As described above, the chemical injection device 100 of the present embodiment is configured such that the computer unit 120 operates in response to the computer program and the control data for the test injection, so that the pressure detection means 151, the graph generation means 152, the graph storage Means 153, graph display means 154, graph comparison means 156, abnormality detection means 157, warning notification means 158, drive control means 159, input operation means 161, graph registration means 162, etc. The
[0048] これら各手段は、必要によりロードセル 142やサブタツチパネル 104などのハードウ エアを一部として使用するが、基本的には CPU 121が ROM 122のコンピュータプロ グラムに対応して所定のデータ処理を実行する機能などに相当する。  [0048] Each of these means uses hardware such as the load cell 142 and the sub-touch panel 104 as a part if necessary, but basically the CPU 121 performs predetermined data processing corresponding to the computer program in the ROM 122. It corresponds to the function to execute.
[0049] 圧力検出手段 151は、詳細には後述するが、ロードセル 142の検出圧力から被験 者に注入される薬液の圧力を検出する。グラフ生成手段 152は、試験注入の実行中 に検出される圧力を経時グラフとしてリアルタイムに生成する。グラフ記憶手段 153は 、 CPU121が認識できるように構築された RAM123の記憶エリアなどに相当し、試 験注入が適正に実行されたときの圧力に相当する基準グラフを記憶している。  As will be described in detail later, the pressure detection means 151 detects the pressure of the chemical solution injected into the subject from the detection pressure of the load cell 142. The graph generating means 152 generates the pressure detected during the test injection in real time as a time graph. The graph storage means 153 corresponds to a storage area of the RAM 123 constructed so that the CPU 121 can recognize, and stores a reference graph corresponding to the pressure when the test injection is properly executed.
[0050] グラフ表示手段 154は、図 7に示すように、サブタツチパネル 118に、記憶されてい る基準グラフを表示させるとともに、生成される経時グラフをリアルタイムに表示させる 。グラフ比較手段 156は、既存の画像認識技術などにより経時グラフの形状を基準グ ラフの形状とリアルタイムに比較する。異常検出手段 157は、経時グラフと基準グラフ との形状が類似しないと異常発生を検出する。  [0050] As shown in FIG. 7, the graph display means 154 displays the stored reference graph on the sub-touch panel 118 and also displays the generated time-lapse graph in real time. The graph comparison means 156 compares the shape of the time-lapse graph with the shape of the reference graph in real time using an existing image recognition technique or the like. The abnormality detection means 157 detects the occurrence of an abnormality if the shape of the time graph and the reference graph are not similar.
[0051] 警告報知手段 158は、異常検出手段 157により異常発生が検出されると、異常が 発生した旨をメインタツチパネル 104およびサブタツチパネル 118に表示させるととも にスピーカユニット 105から音として出力させるにより警告を発する。駆動制御手段 1 59は、試験注入の実行時には基準グラフに対応してピストン駆動機構 130を動作制 御し、異常検出手段 157により異常発生が検出されるとピストン駆動機構 130を強制 停止させる。  [0051] When the abnormality detection unit 157 detects an abnormality, the warning notification unit 158 displays that the abnormality has occurred on the main touch panel 104 and the sub touch panel 118 and outputs the sound from the speaker unit 105 as a sound. Will issue a warning. The drive control means 159 controls the operation of the piston drive mechanism 130 corresponding to the reference graph when the test injection is executed, and forcibly stops the piston drive mechanism 130 when an abnormality is detected by the abnormality detection means 157.
[0052] 入力操作手段 161は、異常検出手段 157をサブタツチパネル 118への所定の入力 操作に対応して異常発生を検出した状態とする。グラフ登録手段 162は、サブタツチ パネル 118への所定の入力操作により経時グラフを基準グラフとしてグラフ記憶手段 153に登録する。 The input operation unit 161 sets the abnormality detection unit 157 in a state in which an abnormality has been detected in response to a predetermined input operation to the sub-touch panel 118. The graph registration means 162 is a sub-touch By a predetermined input operation on the panel 118, the time graph is registered in the graph storage means 153 as a reference graph.
[0053] 上述のような薬液注入装置 100の各種手段は、必要によりメインタツチパネル 104 などのハードウエアを利用して実現される力 その主体は、 ROM122等の情報記憶 媒体に格納されたコンピュータプログラムに対応してハードウェアである CPU121が 機能することにより実現されている。  [0053] The various means of the chemical solution injection device 100 as described above are forces realized by using hardware such as the main touch panel 104 as necessary. The main body is a computer program stored in an information storage medium such as the ROM 122. This is realized by the function of the CPU 121, which is hardware, corresponding to the above.
[0054] このようなコンピュータプログラムは、例えば、試験注入が適正に実行されたときの 圧力に相当する基準グラフを RAM123などに記憶させておくこと、試験注入の実行 時に基準グラフに対応してピストン駆動機構 130の動作を制御すること、試験注入の 実行時に被験者に注入される薬液の圧力をロードセル 142の検出圧力から検出する こと、検出される圧力を経時グラフとしてリアルタイムに生成すること、サブタツチパネ ル 118に基準グラフを表示させるとともに経時グラフをリアルタイムに表示させること、 既存の画像認識技術などにより経時グラフの形状を基準グラフの形状とリアルタイム に比較すること、経時グラフと基準グラフとの形状が類似しないと異常発生を検出す ること、サブタツチパネル 118への所定の入力操作に対応して異常発生を検出した 状態とすること、異常発生が検出されるとメインタツチパネル 104およびサブタツチパ ネル 118の表示およびスピーカユニット 105の音声により警告を発すること、異常発 生が検出されるとピストン駆動機構 130を強制停止させること、およびサブタツチパネ ル 118への所定の入力操作により経時グラフを基準グラフとして登録すること等の処 理動作を CPU121等に実行させるためのソフトウェアとして RAM123等の情報記憶 媒体に格納されている。  [0054] Such a computer program stores, for example, a reference graph corresponding to the pressure when the test injection is properly executed in the RAM 123, and the piston corresponding to the reference graph when the test injection is executed. Control the operation of the drive mechanism 130, detect the pressure of the chemical injected into the subject during the test injection from the detection pressure of the load cell 142, generate the detected pressure in real time as a graph over time, subtouch panel Display the reference graph in 118 and display the time graph in real time, compare the shape of the time graph with the shape of the reference graph in real time using existing image recognition technology, etc., and the shape of the time graph and the reference graph are similar Otherwise, the occurrence of an abnormality will be detected and the corresponding input operation to the sub touch panel 118 will be supported. If an abnormality is detected, the main touch panel 104 and sub touch panel 118 display and the sound of the speaker unit 105 will give a warning, and if an abnormality is detected, the piston will drive. As software for causing the CPU 121 or the like to execute processing operations such as forcibly stopping the mechanism 130 and registering a time-dependent graph as a reference graph by a predetermined input operation to the sub-touch panel 118, it is stored in an information storage medium such as the RAM 123. Stored.
[0055] [実施の形態の作用]  [0055] [Effect of the embodiment]
上述のような構成において、本形態の薬液注入装置 100を使用する場合、図 3〖こ 示すように、 MRI装置 300の透視撮像ユニット 301の近傍に薬液注入装置 100の注 入ヘッド 110を配置しておき、透視撮像ユニット 301から離れた所定位置に注入制御 ユニット 101を配置しておく。  In the configuration as described above, when the liquid injector 100 of this embodiment is used, the injection head 110 of the liquid injector 100 is arranged in the vicinity of the fluoroscopic imaging unit 301 of the MRI apparatus 300 as shown in FIG. The injection control unit 101 is disposed at a predetermined position away from the fluoroscopic imaging unit 301.
[0056] このような状態で、例えば、作業者は注入ヘッド 110の近傍に移動し、透視撮像ュ ニット 301に位置する被験者 (図示せず)に二股の延長チューブ 230で 2つの薬液シリ ンジ 200 (造影剤シリンジ 200Cおよび生理食塩水シリンジ 200P)を連結する。そし て、これらの薬液シリンジ 200のシリンダ部材 210を注入ヘッド 110の凹部 114に保 持させ、ピストン部材 220をピストン駆動機構 130に把持させる。 [0056] In such a state, for example, the operator moves to the vicinity of the injection head 110, and the subject (not shown) located in the fluoroscopic imaging unit 301 is in contact with the two chemical liquid series using the bifurcated extension tube 230. Link 200 (contrast medium syringe 200C and saline syringe 200P). Then, the cylinder member 210 of these chemical solution syringes 200 is held in the recess 114 of the injection head 110, and the piston member 220 is gripped by the piston drive mechanism 130.
[0057] つぎに、作業者は注入ヘッド 110の近傍から注入制御ユニット 101の近傍まで移動 し、そのメイン操作パネル 103の入力操作などで薬液注入装置 100を起動させる。す ると、図 8および図 11に示すように、メインタツチパネル 104の上部に複数の身体区 分の模式画像が人体形状に対応して表示されるとともに、その下方に、薬液の注入 速度を縦軸とし注入時間を横軸とした横長の矩形の条件画面が表示される (ステップ Sl)。 Next, the operator moves from the vicinity of the injection head 110 to the vicinity of the injection control unit 101, and activates the chemical injection device 100 by an input operation on the main operation panel 103 or the like. Then, as shown in FIG. 8 and FIG. 11, a schematic image of a plurality of body sections is displayed on the upper part of the main touch panel 104 corresponding to the human body shape, and the injection rate of the medicinal solution is displayed below it. A horizontally long condition screen with the vertical axis and injection time on the horizontal axis is displayed (Step Sl).
[0058] そこで、メインタツチパネル 104に表示された複数の身体区分の模式画像の 1つを 作業者が手指で接触することによって選択すると (ステップ S2)、図 9に示すように、そ の選択された身体区分の模式画像のみ明転するとともに他の模式画像は暗転し、選 択された身体区分の模式画像の上方にスキャナ機構の模式画像が表示される。  [0058] Therefore, when one of the schematic images of the plurality of body sections displayed on the main touch panel 104 is selected by the operator touching with a finger (step S2), the selection is performed as shown in FIG. Only the schematic image of the selected body section is brightened and the other schematic images are darkened, and the schematic image of the scanner mechanism is displayed above the schematic image of the selected body section.
[0059] 同時に、その下部には選択された身体区分に関連する複数の撮像部位の模式画 像が読み出されて表示されるので (ステップ S3、 S4)、その 1つを作業者が手指で接 触することによって選択すると (ステップ S5)、図 10に示すように、その選択された 1つ の模式画像のみが明転するとともに他の模式画像は暗転する。  [0059] At the same time, a schematic image of a plurality of imaging regions related to the selected body segment is read and displayed at the bottom (steps S3 and S4), one of which is manually performed by the operator. When selected by touching (step S5), as shown in FIG. 10, only one selected schematic image is brightened and the other schematic images are darkened.
[0060] 上述のように撮像部位が選択されると、本形態の薬液注入装置 100では、その撮 像部位に対応して複数種類の薬液シリンジ 200が RAM123に登録されているか確 認され (ステップ S6)、複数種類の薬液シリンジ 200が登録されていると、その識別デ ータとなる製品名称や容量などがメインタツチパネル 104およびサブタツチパネル 11 8に一覧表示される (ステップ S7)。  [0060] When an imaging region is selected as described above, in the chemical injection device 100 of the present embodiment, it is confirmed whether or not a plurality of types of chemical syringes 200 are registered in the RAM 123 corresponding to the imaging region (step If a plurality of types of liquid syringes 200 are registered, product names and capacities that are identification data are listed in the main touch panel 104 and the sub touch panel 118 (step S7).
[0061] つまり、本形態の薬液注入装置 100では、複数種類の造影剤シリンジ 200Cおよび 生理食塩水シリンジ 200Pが使用されるので、その使用される造影剤シリンジ 200C および生理食塩水シリンジ 200Pの各種データが事前に登録されている。さらに、そ の薬液シリンジ 200の各種データは撮像部位と関連されて登録されて 、るので、上 述のように撮像部位が選択されると対応する薬液シリンジ 200の製品名称などが一 覧表示される。 [0062] そこで、作業者がサブタツチパネル 118で薬液シリンジ 200を選択操作すると、そ の選択された薬液シリンジ 200の各種データが読み出される (ステップ S9)。このとき、 例えば、選択されな力つた薬液シリンジ 200の表示データは消去され、選択された薬 液シリンジ 200のみ表示データが拡大されるので、作業者は薬液シリンジ 200の選 択結果を確実に確認することができる。 That is, in the liquid injector 100 of this embodiment, since a plurality of types of contrast medium syringe 200C and physiological saline syringe 200P are used, various data of the contrast medium syringe 200C and the physiological saline syringe 200P that are used. Is registered in advance. Furthermore, since the various data of the chemical syringe 200 are registered in association with the imaging region, when the imaging region is selected as described above, the corresponding product name of the chemical syringe 200 is displayed in a list. The [0062] Therefore, when the operator selects and operates the chemical syringe 200 on the sub-touch panel 118, various data of the selected chemical syringe 200 are read (step S9). At this time, for example, the display data of the selected chemical syringe 200 is erased, and the display data of only the selected chemical syringe 200 is expanded, so that the operator confirms the selection result of the chemical syringe 200 with certainty. can do.
[0063] なお、本形態の薬液注入装置 100は、前回使用された薬液シリンジ 200を記憶し ており、前回使用された薬液シリンジ 200は一覧表示されるときに点滅や反転などで 表示されるので、作業者は使用する薬液シリンジ 200が前回と同一のときは簡単に 選択操作を実行することができる。  [0063] It should be noted that the liquid injector 100 of the present embodiment stores the liquid syringe 200 that was used last time, and the liquid syringe 200 that was used last time is displayed by blinking or inversion when displayed as a list. The operator can easily execute the selection operation when the chemical syringe 200 to be used is the same as the previous one.
[0064] し力も、薬液シリンジ 200の選択操作を注入ヘッド 110のサブタツチパネル 118でも 実行できるので、注入ヘッド 110に実際に装着されて 、る造影剤シリンジ 200Cおよ び生理食塩水シリンジ 200Pを確認しながらサブタツチパネル 118で選択操作を確 実に実行することもできる。  [0064] Since the selection operation of the chemical syringe 200 can also be performed on the sub-touch panel 118 of the injection head 110, the contrast medium syringe 200C and the physiological saline syringe 200P that are actually attached to the injection head 110 are installed. It is also possible to execute the selection operation with the sub touch panel 118 while confirming.
[0065] なお、撮像部位に対応して造影剤シリンジ 200Cおよび生理食塩水シリンジ 200P 力 種類ずつしか登録されていないときは (ステップ S6)、その薬液シリンジ 200の各 種データが自動的に読み出され、その製品名称や容量などがメインタツチパネル 10 4およびサブタツチパネル 118に拡大表示される (ステップ S9)。  [0065] If only the contrast medium syringe 200C and the physiological saline syringe 200P force type are registered corresponding to the imaging site (step S6), the various types of data of the drug syringe 200 are automatically read out. The product name, capacity, etc. are enlarged and displayed on the main touch panel 104 and the sub touch panel 118 (step S9).
[0066] 本形態の薬液注入装置 100では、使用される造影剤シリンジ 200Cおよび生理食 塩水シリンジ 200Pごとに、シリンダ部材 210の内径、ピストン部材 220のストローク、 シリンダ部材 210とピストン部材 220との摩擦力、充填されている薬液の容量、薬液 の粘度、等の各種データが登録されているので、これらの各種データが造影剤シリン ジ 200Cおよび生理食塩水シリンジ 200Pの選択操作に対応して読み出される。  [0066] In the chemical injection device 100 of this embodiment, for each contrast medium syringe 200C and physiological saline syringe 200P used, the inner diameter of the cylinder member 210, the stroke of the piston member 220, and the friction between the cylinder member 210 and the piston member 220 Various data such as force, volume of filled chemical solution, viscosity of chemical solution, etc. are registered, so these various data are read out corresponding to the selection operation of contrast medium syringe 200C and physiological saline syringe 200P .
[0067] 上述のように撮像部位と薬液シリンジ 200とが選定されると、本形態の薬液注入装 置 100では、その撮像部位と薬液シリンジ 200とに対応して正式注入の前回の注入 条件が RAMI 23に登録されて!、るか確認され (ステップ S 10)、登録されて!、な!/、と デフォルトの注入条件が読み出され (ステップ Sl l)、登録されているならば前回の注 入条件が読み出される (ステップ S 12)。  [0067] When the imaging region and the chemical syringe 200 are selected as described above, in the chemical injection device 100 of the present embodiment, the previous injection conditions for the formal injection correspond to the imaging region and the chemical syringe 200. It is confirmed whether it is registered in RAMI 23 (step S 10), registered !, na! /, And the default injection conditions are read (step Sl l). The injection condition is read (step S12).
[0068] なお、本形態の薬液注入装置 100では、正式注入では造影剤と生理食塩水とが順 番に注入されるので、この注入が実行されるように造影剤と生理食塩水との注入条件 が登録されている。このように読み出された注入条件には注入時間と注入速度とが データ設定されて ヽるので、その注入時間と注入速度とが乗算されて注入容量が注 入条件ごとに算出される (ステップ S13)。 [0068] It should be noted that in the chemical injection device 100 of this embodiment, the contrast agent and the physiological saline are sequentially used in the formal injection. The injection conditions of contrast medium and physiological saline are registered so that this injection is executed. Since the injection time and the injection rate are set as data for the injection conditions read out in this way, the injection time and the injection speed are multiplied to calculate the injection volume for each injection condition (step S13).
[0069] そして、注入時間に対応した横幅で注入速度と注入容量とがテキストデータで付与 された条件画像が注入条件ごとにデータ生成され (ステップ S 14)、図 10に示すように 、その条件画像が注入速度に対応した縦位置と注入時間に対応した横位置とで条 件画面に表示出力される (ステップ S 17)。  [0069] Then, a condition image in which the injection speed and the injection volume are given as text data in a width corresponding to the injection time is generated for each injection condition (step S14), and as shown in FIG. The image is displayed and output on the condition screen at a vertical position corresponding to the injection speed and a horizontal position corresponding to the injection time (step S17).
[0070] このとき、前述のように造影剤と生理食塩水との注入条件力も条件画像がデータ生 成されるので、例えば、その条件画像は緑色と青色とで表示出力され、横方向に順 番に配列されて表示出力される。また、注入条件ごとに注入速度が上限速度を超過 して 、るかが判定され (ステップ S 15)、超過して 、る注入条件は条件画像が赤色で点 滅表示されることで速度警告が出力される (ステップ S 16)。  [0070] At this time, as described above, the condition image is also generated for the injection condition force of the contrast medium and the physiological saline as described above. For example, the condition image is displayed and output in green and blue, and sequentially in the horizontal direction. Are displayed and output. In addition, it is determined for each injection condition whether the injection speed exceeds the upper limit speed (step S15) .If the injection speed exceeds, the condition image flashes in red and a speed warning is issued. Is output (step S16).
[0071] 本形態の薬液注入装置 100は、図 12に示すように、上述のようにメインタツチパネ ル 104に表示された注入条件を、メインタツチパネル 104の操作により所望により変 更することができる (ステップ S 18、 S19)。例えば、メインタツチパネル 104に表示され た条件画像の中央に作業者が手指を接触させ、接触させた手指を条件画像上で上 下にスライドさせることで注入条件の注入速度を増減させることができる。  As shown in FIG. 12, the chemical injection device 100 of the present embodiment can change the injection conditions displayed on the main touch panel 104 as described above by operating the main touch panel 104 as desired. Yes (Steps S18, S19). For example, the injection speed of the injection condition can be increased or decreased by bringing the finger into contact with the center of the condition image displayed on the main touch panel 104 and sliding the contacted finger up or down on the condition image. .
[0072] また、表示された条件画像の左右の両端の少なくとも一方に手指を接触させ、接触 させた手指を左右にスライドさせることで注入条件の注入時間と注入容量とを増減さ せることができる。さらに、表示された条件画像の注入速度や注入容量の数値に手 指を接触させると、そこにテンキーの操作画像が表示されるので (図示せず)、そのテ ンキーを入力操作することでも注入速度や注入容量を増減させることができる。  [0072] Further, the injection time and the injection volume of the injection conditions can be increased or decreased by bringing a finger into contact with at least one of the left and right ends of the displayed condition image and sliding the contacted finger to the left or right. . In addition, when you touch your finger on the injection speed and injection volume values in the displayed condition image, an operation image of the numeric keypad is displayed there (not shown). The rate and volume of injection can be increased or decreased.
[0073] このようにメインタツチパネル 104に表示された条件画像により正式注入の注入条 件が入力操作されると (ステップ S18)、これが今回の注入条件として記憶され (ステツ プ S12)、その注入条件に対応して条件画像の生成などもリアルタイムに実行される( ステップ313〜319)。  [0073] As described above, when the injection condition for formal injection is input by the condition image displayed on the main touch panel 104 (step S18), this is stored as the current injection condition (step S12). A condition image is generated in real time corresponding to the condition (steps 313 to 319).
[0074] 本形態の薬液注入装置 100では、上述のように正式注入の注入条件が確定される と、前述のように選定された撮像部位と薬液シリンジ 200とに対応して、試験注入の 経時グラフが基準グラフとして RAM123に登録されている力確認される (ステップ S2 0)。 [0074] In the chemical injection device 100 of the present embodiment, the injection conditions for formal injection are determined as described above. Corresponding to the imaging region selected as described above and the chemical syringe 200, the force registered in the RAM 123 as the reference graph is confirmed as the time chart of the test injection (step S20).
[0075] 経時グラフが登録されて 、な 、場合は、撮像部位と薬液シリンジ 200とに対応して デフォルト設定されて 、る基準グラフが読み出され、サブタツチパネル 118に表示さ れる (ステップ S23)。一方、撮像部位と薬液シリンジ 200とに対応して経時グラフが登 録されている場合は、その経時グラフが読み出されてサブタツチパネル 118に基準グ ラフとして表示される (ステップ S21)。  [0075] If the time graph is registered, in this case, the default graph corresponding to the imaging region and the chemical syringe 200 is read, and the reference graph is read and displayed on the sub touch panel 118 (step S23). ). On the other hand, if a time-dependent graph is registered corresponding to the imaging region and the chemical syringe 200, the time-dependent graph is read and displayed as a reference graph on the sub-touch panel 118 (step S21).
[0076] この場合、例えば、サブタツチパネル 118に「試験注入をユーザ設定で実行します  [0076] In this case, for example, the sub-touch panel 118 “executes test injection with user settings.
YZN」などのガイダンスメッセージとともに、デフォルト設定の基準グラフと、基準 グラフとして登録されている経時グラフと、が表示される。このため、作業者は登録さ れている経時グラフを使用するかデフォルト設定の基準グラフを使用する力も、サブ タツチパネル 118で選択操作することができる (ステップ S22)。  The default reference graph and the time graph registered as the reference graph are displayed along with guidance messages such as “YZN”. For this reason, the operator can also select and operate the power to use the registered time graph or the default reference graph on the sub touch panel 118 (step S22).
[0077] そこで、作業者が所望の基準グラフを選定すると、その基準グラフのみがサブタツ チパネル 118に表示された状態となるので、このような状態で作業者がサブタツチパ ネル 118に試験開始を入力操作すると (ステップ S24)、初期設定および試験注入が 実行される (ステップ S25〜)。 [0077] Therefore, when the operator selects a desired reference graph, only the reference graph is displayed on the sub-touch panel 118. In this state, the operator inputs a test start to the sub-touch panel 118. Then (step S24), initial setting and test injection are performed (step S25 ~).
[0078] その場合、最初にコンピュータユニット 120が生理食塩水注入機構 130Pおよび造 影注入機構 130Cの超音波モータ 143を作動させない状態でロードセル 142から電 気信号として電気抵抗を取得し (ステップ S25)、その電気抵抗が「0」の圧力を示して V、るとして初期設定を実行する (ステップ S26)。 In that case, first, the computer unit 120 acquires electrical resistance as an electrical signal from the load cell 142 without operating the ultrasonic motor 143 of the physiological saline injection mechanism 130P and the design injection mechanism 130C (step S25). The initial setting is executed assuming that the electric resistance indicates a pressure of “0” V (step S26).
[0079] つぎに、コンピュータユニット 120は、基準グラフに対応して生理食塩水注入機構 1 30Pのみ超音波モータ 143を作動させることで、試験注入を実行する (ステップ S27) 。このとき、図 6に示すように、超音波モータ 143とベルト機構 144で連結されている スクリューシャフト 137が回転駆動されるが、このスクリューシャフト 137はヘッド本体 1 13に固定されているロードセル 142によりスラスト軸受 139を介して軸心方向に支持 されているので、スクリューシャフト 137とネジ機構により連結されているスライドロッド 131がスライド移動される。 [0080] そこで、このスライドロッド 131によりピストン部材 220がシリンダ部材 210に押し込ま れ、このシリンダ部材 210から被験者に薬液が注入される。このとき、ピストン部材 22 0を押圧するスライドロッド 131に作用する圧力がスクリューシャフト 137にも作用する ので、このスクリューシャフト 137に作用する圧力がスラスト軸受 139を介してロードセ ル 142に作用する。 Next, the computer unit 120 executes test injection by operating the ultrasonic motor 143 only for the physiological saline injection mechanism 130P corresponding to the reference graph (step S27). At this time, as shown in FIG. 6, the screw shaft 137 connected by the ultrasonic motor 143 and the belt mechanism 144 is rotationally driven. The screw shaft 137 is driven by the load cell 142 fixed to the head body 113. Since it is supported in the axial direction through the thrust bearing 139, the slide rod 131 connected to the screw shaft 137 by the screw mechanism is slid. Accordingly, the piston member 220 is pushed into the cylinder member 210 by the slide rod 131, and the chemical solution is injected from the cylinder member 210 to the subject. At this time, the pressure acting on the slide rod 131 that presses the piston member 220 also acts on the screw shaft 137, so that the pressure acting on the screw shaft 137 acts on the load cell 142 via the thrust bearing 139.
[0081] そこで、図 12に示すように、コンピュータユニット 120は、上述のように薬液注入の 実行中にロードセル 142が検出する圧力を取得し (ステップ S28)、シリンジ選択により 初期設定された薬液の粘度ゃシリンダ部材 210の内径などに対応して、ピストン部材 220の押し込み圧力を薬液の注入圧力に換算する (ステップ S29)。  Therefore, as shown in FIG. 12, the computer unit 120 obtains the pressure detected by the load cell 142 during the execution of the chemical solution injection as described above (step S28), and the initial value of the chemical solution set by the syringe selection is obtained. The viscosity corresponds to the inner diameter of the cylinder member 210 and the like, and the pushing pressure of the piston member 220 is converted into the chemical injection pressure (step S29).
[0082] このため、本形態の薬液注入装置 100では、作業者はピストン部材 220に作用す る圧力から薬液の注入圧力を類推するような必要がなぐ薬液の注入圧力を容易に 確認することができる。しカゝも、ピストン部材 220の圧力を薬液の注入圧力に換算す るために必要な各種データは、前述のように一覧表示された薬液シリンジ 200を選択 操作するだけで設定されるので (ステップ S8、 S9)、作業者に煩雑なデータ入力が要 求されることもない。  [0082] For this reason, in the chemical injection device 100 of this embodiment, the operator can easily confirm the injection pressure of the chemical solution that does not need to analogize the injection pressure of the chemical solution from the pressure acting on the piston member 220. it can. However, since the various data necessary to convert the pressure of the piston member 220 into the injection pressure of the chemical solution is set just by selecting and operating the chemical syringe 200 listed as described above (Step S8, S9), no complicated data input is required for the operator.
[0083] そして、図 7に示すように、この注入圧力力 経時グラフがリアルタイムに生成されて サブタツチパネル 118に表示されるので (ステップ S30)、作業者は実際に試験注入さ れている薬液の注入圧力が基準グラフに対応しているかをリアルタイムに簡単に確 認することができる。  [0083] Then, as shown in FIG. 7, since this injection pressure force time graph is generated in real time and displayed on the sub-touch panel 118 (step S30), the operator can actually carry out the chemical solution injected in the test. It can be easily confirmed in real time whether the injection pressure of the gas corresponds to the reference graph.
[0084] なお、本形態の薬液注入装置 100では、撮像部位と薬液シリンジ 200とに対応して 試験注入の上限圧力もデフォルト設定されて ヽるので、試験注入の最中には注入圧 力が上限圧力を超過しないかが常時監視される (ステップ S31)。もしも注入圧力が上 限圧力を超過した場合は、異常発生がメインタツチパネル 104およびサブタツチパネ ル 118の表示とスピーカユニット 105の音声出力とで出力され (ステップ S35)、生理 食塩水注入機構 130Pの作動が強制停止される (ステップ S36)。このため、作業者は 試験注入に異常圧力が発生したことを迅速かつ確実に認識することができ、異常圧 力が発生したまま試験注入が継続されることが自動的に防止される。  [0084] It should be noted that in the chemical injection device 100 of this embodiment, the upper limit pressure of the test injection is also set by default corresponding to the imaging site and the chemical syringe 200, so that the injection pressure is increased during the test injection. Whether or not the upper limit pressure is exceeded is constantly monitored (step S31). If the injection pressure exceeds the upper limit pressure, an abnormality is output from the main touch panel 104 and sub touch panel 118 display and the audio output of the speaker unit 105 (step S35), and the physiological saline injection mechanism 130P is activated. Is forcibly stopped (step S36). For this reason, the operator can quickly and reliably recognize that an abnormal pressure has occurred in the test injection, and automatically prevent the test injection from continuing while the abnormal pressure is generated.
[0085] また、本形態の薬液注入装置 100は、基準グラフに対応して生理食塩水注入機構 130Pを駆動することで試験注入を実行するので、試験注入が正常に実行されて!ヽ ると経時グラフの形状が基準グラフの形状と類似することになる。そこで、コンピュータ ユニット 120は、例えば、既存の画像認識の技術により経時グラフの形状と基準ダラ フの形状とをリアルタイムに比較し (ステップ S32)、両グラフの形状が類似しな 、と異 常発生を検出する。 [0085] Further, the chemical injection device 100 of the present embodiment corresponds to the physiological saline injection mechanism corresponding to the reference graph. Since the test injection is executed by driving 130P, if the test injection is executed normally, the shape of the graph over time is similar to the shape of the reference graph. Therefore, for example, the computer unit 120 compares the shape of the graph over time with the shape of the reference graph in real time using the existing image recognition technology (step S32), and an abnormality occurs when the shapes of both graphs are similar. Is detected.
[0086] 例えば、試験注入の最中に延長チューブ 230の注射針 (図示せず)が血管から外れ たが筋肉中に残存しているような場合、経時グラフは短時間に急激に低下する。しか し、もともと経時グラフが基準グラフより高圧であった場合、その経時グラフの圧力が 低下しても基準グラフの圧力との差分からは異常発生を検出できないことがある。  [0086] For example, when the injection needle (not shown) of the extension tube 230 is removed from the blood vessel but remains in the muscle during the test injection, the time-lapse graph rapidly decreases in a short time. However, if the time graph is originally higher than the reference graph, the occurrence of an abnormality may not be detected from the difference from the pressure of the reference graph even if the pressure of the time graph decreases.
[0087] 反対に、試験注入の最中に延長チューブ 230が折り曲がったような場合、経時ダラ フは短時間に急激に上昇するが、もともと経時グラフが基準グラフより低圧であった 場合、その上昇した圧力と基準グラフの圧力との差分力 は異常発生を検出できな いことがある。  [0087] On the other hand, if the extension tube 230 is bent during the test injection, the time-lapse graph rises rapidly in a short time, but if the time-lapse graph is originally lower in pressure than the reference graph, The differential force between the increased pressure and the pressure in the reference graph may not detect the occurrence of an abnormality.
[0088] しかし、本形態の薬液注入装置 100では、基準グラフの形状と経時グラフの形状と が類似しないと異常発生を検出するので、上述のように圧力差が充分でなくとも異常 発生を検出することができる。なお、基準グラフと経時グラフとに充分な圧力差が発 生した場合は、形状が類似していないと判定されるので、やはり異常発生が検出され る。上述のように基準グラフと経時グラフとの形状の類似を判断する技術は、例えば、 OCR(Optical Character Reader)などに利用されている認識技術を利用することが可 能である。  [0088] However, in the chemical injection device 100 of the present embodiment, the occurrence of an abnormality is detected if the shape of the reference graph and the shape of the time-dependent graph are not similar, and thus the occurrence of an abnormality is detected even if the pressure difference is not sufficient as described above can do. When a sufficient pressure difference is generated between the reference graph and the time-lapse graph, it is determined that the shapes are not similar, and thus an abnormality is detected. As described above, for example, a recognition technique used in OCR (Optical Character Reader) or the like can be used as a technique for determining the similarity in shape between the reference graph and the time-dependent graph.
[0089] さらに、本形態の薬液注入装置 100では、例えば、サブタツチパネル 118に表示さ れている基準グラフの上方や下方を試験注入の実行中に手指で接触することにより( ステップ S32)、試験注入の圧力をリアルタイムに調整することもできる (ステップ S27) 。そして、このように手動操作された経時グラフは基準グラフとの類似が比較されない ので (ステップ S33)、作業者の所望により経時グラフが基準グラフとは類似しない状 態で試験注入を実行することもできる。  [0089] Furthermore, in the chemical injection device 100 of the present embodiment, for example, by touching the upper or lower portion of the reference graph displayed on the sub-touch panel 118 with fingers during execution of the test injection (step S32), The test injection pressure can also be adjusted in real time (step S27). Since the manually operated time graph is not compared with the reference graph (step S33), the test injection may be performed in a state where the time graph is not similar to the reference graph according to the operator's request. it can.
[0090] さらに、本形態の薬液注入装置 100では、上述のように基準グラフとともに経時ダラ フがリアルタイムに表示されるので、作業者の判断により異常発生をサブタツチパネ ル 118に入力操作することもできる (ステップ S34)。その場合も、生理食塩水注入機 構 130Pの作動が強制停止されるので (ステップ S36)、作業者に異常と判断された経 時グラフが基準グラフとして登録されることはな 、。 [0090] Further, in the chemical injection device 100 of the present embodiment, the time-lapse dull is displayed in real time together with the reference graph as described above, so that the occurrence of abnormality is determined by the operator's judgment on the sub touch panel. It is also possible to perform an input operation on the button 118 (step S34). Even in that case, since the operation of the physiological saline injection mechanism 130P is forcibly stopped (step S36), the time graph determined to be abnormal by the operator is not registered as the reference graph.
[0091] なお、上述のように異常発生により試験注入が中断されると、作業者は異常原因を 究明して対処することになる。その場合、薬液シリンジ 200の交換などが必要となるこ とはあるが、通常は撮像部位の変更などは必要ない。そこで、本形態の薬液注入装 置 100では、試験注入が異常発生により中断されると (ステップ S36)、図 11に示すよ うに、撮像部位が選択された状態力 作業を再開することができるので (ステップ S6) 、無用な入力操作を必要とすることなく迅速に試験注入を再開することができる。  [0091] As described above, when the test injection is interrupted due to the occurrence of an abnormality, the operator will investigate the cause of the abnormality and deal with it. In that case, the chemical solution syringe 200 may need to be replaced, but usually there is no need to change the imaging site. Therefore, in the chemical injection device 100 of this embodiment, when the test injection is interrupted due to the occurrence of an abnormality (step S36), as shown in FIG. 11, the state force operation with the selected imaging region can be resumed. (Step S6) The test injection can be resumed quickly without the need for unnecessary input operations.
[0092] そして、生理食塩水注入機構 130Pの作動距離など力も注入完了が検出されるま で (ステップ S37)、上述の試験注入の動作が繰り返される (ステップ S27〜S37)。この 試験注入が問題なく完了すると (ステップ S37)、図 13に示すように、生理食塩水注入 機構 130Pの作動が停止される (ステップ S38)。  [0092] Then, the above-described test injection operation is repeated (steps S27 to S37) until the completion of the injection is detected for the force such as the working distance of the physiological saline injection mechanism 130P (step S37). When this test injection is completed without any problem (step S37), as shown in FIG. 13, the operation of the physiological saline injection mechanism 130P is stopped (step S38).
[0093] すると、サブタツチパネル 118には、基準グラフと経時グラフとが表示されたまま、「 今回の注入グラフを次回以降の基準グラフとして登録しますか? YZN」などのガイ ダンスメッセージが表示される。そこで、今回の試験注入の経時グラフが現状の基準 グラフより適切で登録した 、と作業者が判断した場合、作業者は「Y」を手動操作する (ステップ S39)。  [0093] Then, on the sub-touch panel 118, a guidance message such as “Do you want to register this injection graph as a reference graph for the next and subsequent times? YZN” is displayed with the reference graph and time graph displayed. Is done. Therefore, when the operator determines that the time graph of the current test injection is registered more appropriately than the current reference graph, the operator manually operates “Y” (step S39).
[0094] すると、今回の経時グラフが基準グラフとして登録されるので (ステップ S40)、次回 力も登録されている経時グラフを基準グラフとして使用できることになる (ステップ S20 〜S23)。このため、上限圧力を超過することなく現状の基準グラフとの類似が確認さ れた経時グラフを (ステップ S31、 S33)、作業者の所望により新規の基準グラフとして 登録することができる (ステップ S40)。  Then, since the current time graph is registered as the reference graph (step S40), the time graph in which the next force is also registered can be used as the reference graph (steps S20 to S23). Therefore, a time-lapse graph that has been confirmed to be similar to the current reference graph without exceeding the upper limit pressure (steps S31 and S33) can be registered as a new reference graph as desired by the operator (step S40). ).
[0095] し力も、作業者の手動操作により基準グラフとは類似しない経時グラフが生成され た場合でも (ステップ S32)、その経時グラフを新規の基準グラフとして作業者の所望 により登録することもできる (ステップ S40)。特に、このように作業者の所望により試験 注入が手動操作される場合でも、その注入圧力は上限圧力を超過しない範囲に制 限されるので (ステップ S31)、試験注入が異常圧力で実行されることはなく (ステップ S 36)、危険な経時グラフが基準グラフとして登録されることもな!/、。 [0095] Even when a time graph that is not similar to the reference graph is generated manually by the operator (step S32), the time graph can be registered as a new reference graph as desired by the operator. (Step S40). In particular, even if the test injection is manually operated as desired by the operator, the injection pressure is limited to a range that does not exceed the upper limit pressure (step S31), so the test injection is executed at an abnormal pressure. (Step S 36) Dangerous time graphs may not be registered as reference graphs! /.
[0096] そして、このように独自の経時グラフが新規の基準グラフとして登録された場合でも 、その基準グラフに対応して次回の試験注入が実行され、その基準グラフと新規の 経時グラフとの波形の比較により異常の有無が判断される。このため、本形態の薬液 注入装置 100では、作業者の所望により基準グラフが変更されても、試験注入の異 常発生を良好に検出することができる。 [0096] Even when the original time-dependent graph is registered as a new reference graph in this way, the next test injection is executed corresponding to the reference graph, and the waveform of the reference graph and the new time-based graph is displayed. The presence or absence of an abnormality is determined by comparison. For this reason, in the chemical injection device 100 according to the present embodiment, even if the reference graph is changed according to the operator's request, it is possible to detect abnormal occurrence of the test injection.
[0097] さらに、基準グラフとして登録される経時グラフは撮像部位と薬液シリンジ 200とに 対応して登録され、前述のように撮像部位と薬液シリンジ 200とを選択操作すれば (ス テツプ S1〜S8)、対応する基準グラフが自動的に読み出されるので (ステップ S20〜 S23)、撮像部位と薬液シリンジ 200とに対応した基準グラフを簡単に登録して読み 出すことができる。 [0097] Further, the time-lapse graph registered as the reference graph is registered corresponding to the imaging region and the chemical syringe 200, and if the imaging region and the chemical syringe 200 are selected and operated as described above (Steps S1 to S8). ), The corresponding reference graph is automatically read out (steps S20 to S23), so that the reference graph corresponding to the imaging region and the drug solution syringe 200 can be easily registered and read out.
[0098] なお、今回の試験注入の経時グラフが現状の基準グラフより適切ではないと作業者 が判断した場合、作業者は「N」を手動操作することになるので、今回の経時グラフは 基準グラフとして登録されることなく消去され、現状の基準グラフが次回も使用される ことになる。  [0098] If the operator determines that the time chart of the current test injection is not more appropriate than the current reference graph, the operator will manually operate “N”, so the current time graph is the reference It will be deleted without being registered as a graph, and the current reference graph will be used next time.
[0099] そして、本形態の薬液注入装置 100は、上述のように試験注入が完了すると (ステツ プ S39、 S40)、正式注入を実行できる状態となる (ステップ S41〜)。その場合、作業 者は注入ヘッド 110の近傍力も注入制御ユニット 101の近傍まで移動し、そのメイン タツチパネル 104に正式注入の作業開始を入力操作する。すると、これを検知した薬 液注入装置 100は (ステップ S41)、作業開始を MRI装置 300に送信する (ステップ S 44)。  [0099] Then, when the test injection is completed as described above (steps S39 and S40), the chemical injection device 100 of the present embodiment is in a state in which formal injection can be executed (steps S41 to S41). In that case, the operator also moves the vicinity force of the injection head 110 to the vicinity of the injection control unit 101, and inputs a start operation of formal injection to the main touch panel 104. Then, the chemical injection device 100 that has detected this (step S41) transmits a work start to the MRI apparatus 300 (step S44).
[0100] 図 14に示すように、このように薬液注入装置 100から作業開始を受信した MRI装 置 300は (ステップ T2)、作業開始を薬液注入装置 100に返信して撮像動作を実行 する (ステップ Τ8)。このため、本形態の薬液注入システム 1000では、薬液注入装置 100の薬液注入に MRI装置 300の画像撮像が追従することになる。  [0100] As shown in FIG. 14, the MRI apparatus 300 that has received the work start from the chemical injection device 100 in this way (step T2) returns the work start to the chemical injection device 100 and executes the imaging operation ( Step Τ8). For this reason, in the chemical injection system 1000 of this embodiment, the imaging of the MRI apparatus 300 follows the chemical injection of the chemical injection apparatus 100.
[0101] なお、本形態の薬液注入システム 1000では、前述のように薬液注入装置 100が正 式注入の準備完了の状態で (ステップ S41〜S43)、図 14に示すように、 MRI装置 30 0に撮像開始が入力操作された場合も (ステップ Tl)、 MRI装置 300の画像撮像に薬 液注入装置 100の薬液注入が追従する (ステップ T4、 T6〜、 S42、 S47〜)。 [0101] In the chemical injection system 1000 of this embodiment, as described above, the chemical injection device 100 is in a state where preparation for normal injection is completed (steps S41 to S43), and as shown in FIG. When the start of imaging is input (step Tl), the MRI 300 The liquid injection of the liquid injection device 100 follows (steps T4, T6 ~, S42, S47 ~).
[0102] なお、図 13に示すように、薬液注入装置 100が薬液注入の一連の作業を実行する 場合 (ステップ S48〜)、その注入開始力も経過時間が計測され (ステップ S48)、その 経過時間と読み出されている注入条件とに対応して造影剤注入機構 130Cと生理食 塩水注入機構 130Pとがリアルタイムに順番に動作制御される (ステップ S49)。 [0102] As shown in Fig. 13, when the chemical injection device 100 performs a series of chemical injection operations (from step S48), the injection start force is also measured for the elapsed time (step S48), and the elapsed time The contrast medium injection mechanism 130C and the physiological saline injection mechanism 130P are sequentially controlled in real time in accordance with the read injection conditions (step S49).
[0103] このときも、コンピュータユニット 120は、ロードセル 142が検出する圧力を取得し (ス テツプ S50)、初期設定された薬液の粘度ゃシリンダ部材 210の内径などに対応して ピストン圧力を注入圧力に換算し (ステップ S51)、この注入圧力が正常かを確認する ( ステップ S 52)。 [0103] Also at this time, the computer unit 120 obtains the pressure detected by the load cell 142 (step S50), and injects the piston pressure corresponding to the initial viscosity of the chemical solution corresponding to the inner diameter of the cylinder member 210, etc. (Step S51) and confirms that this injection pressure is normal (step S52).
[0104] 本形態の薬液注入装置 100および MRI装置 300は、前述の準備完了の状態で異 常発生が検出されたり (ステップ S43、 T3)、動作実行の最中に異常発生が検出され たりすると (ステップ S52、 T9)、その異常発生が出力されるとともに (ステップ S55、 T1 6)、その動作中止が実行される (ステップ S58、 T18)。  [0104] The chemical injection device 100 and the MRI device 300 of the present embodiment detect the occurrence of abnormality in the above-mentioned ready state (steps S43, T3), or detect the occurrence of abnormality during operation execution. (Steps S52 and T9), the occurrence of the abnormality is output (Steps S55 and T16), and the operation is stopped (Steps S58 and T18).
[0105] さらに、その異常発生が他方にも送信されるので (ステップ S54、 T15)、これを受信 した他方でも (ステップ T10、 S44)、やはり異常発生が出力される (ステップ T16、 S46 )οまた、一方の動作中止も他方に送信されるので (ステップ S56、 T17)、これを受信 した他方でも (ステップ T13、 S53)、その動作中止が実行される (ステップ T18、 S57)  [0105] Furthermore, since the occurrence of the abnormality is also transmitted to the other side (Steps S54, T15), the other side that has received this (Steps T10, S44) also outputs an abnormality occurrence (Steps T16, S46). Also, since one operation stop is also sent to the other (steps S56, T17), the other operation that received this (steps T13, S53) executes the operation stop (steps T18, S57).
[0106] なお、一方に動作中止が入力操作されたときも (ステップ S58、 Tl l)、その動作中 止が実行されるとともに (ステップ S57、 T18)、他方にも送信されるので (ステップ S56 、 Τ17)、これを受信した他方でも (ステップ T13、 S60)、その動作中止が実行される( ステップ T18、 S57)0 [0106] Even when an operation stop is input to one side (step S58, Tl l), the operation stop is executed (step S57, T18) and also sent to the other (step S56). Τ) 17) Even if the other side receives this (step T13, S60), the operation is stopped (step T18, S57) 0
[0107] また、一方で動作完了が検出されたときも (ステップ S61、 T14)、その動作終了が実 行されるとともに (ステップ S62、 T19)、その動作終了が他方に送信されるので (ステツ プ S63、 T20)、これを受信した他方でも (ステップ Tl 2、 S59)、その動作中止が実行 される (ステップ T18、 S57)0 [0107] When the operation completion is detected on one side (steps S61 and T14), the operation end is executed (steps S62 and T19), and the operation end is transmitted to the other side (steps 61). flop S63, T20), the other at even (step Tl 2 which has received this, S59), stops the operation (step T18, S57) 0
[0108] 本形態の薬液注入システム 1000では、上述のように薬液注入装置 100の薬液注 入と MRI装置 300の画像撮像とが自動的に連動するので、造影剤と生理食塩水とが 的確なタイミングで順番に注入される被験者カゝら透視画像を的確なタイミングで撮像 することができる。 [0108] In the drug solution injection system 1000 of this embodiment, as described above, the drug solution injection of the drug solution injection device 100 and the imaging of the MRI device 300 are automatically linked, so that the contrast agent and the physiological saline are separated. It is possible to take a fluoroscopic image of a subject who is injected in order at an appropriate timing at an appropriate timing.
[0109] 本形態の薬液注入装置 100では、上述のように正式注入の各種データは注入制 御ユニット 101に搭載されて ヽる大型で高解像度なメインタツチパネル 104で入力操 作されるとともに表示されるので、正式注入の複雑な入力操作や表示を的確に実行 することができる。  [0109] In the chemical injection device 100 of the present embodiment, as described above, various data of formal injection are input and operated on the large and high-resolution main touch panel 104 mounted on the injection control unit 101 and displayed. Therefore, complicated input operation and display of formal injection can be executed accurately.
[0110] それでいて、試験注入の各種データは注入ヘッド 110に搭載されている小型で低 解像度なサブタツチパネル 118で入力操作されるとともに表示されるので、 1人の作 業者が注入ヘッド 110の近傍で延長チューブ 230などを目視しながら試験注入の入 力操作や確認を容易に実行することができる。  [0110] Nevertheless, since various data of the test injection are input and displayed on the small, low-resolution sub-touch panel 118 mounted on the injection head 110, one operator is in the vicinity of the injection head 110. Thus, it is possible to easily perform the test injection input operation and confirmation while visually observing the extension tube 230 and the like.
[0111] また、本形態の薬液注入装置 100では、ピストン駆動機構 130はヘッド本体 113に 変位可能に支持されており、そのピストン駆動機構 130に作用する圧力を検出する口 ードセル 142はヘッド本体 113に固定されている。このため、ピストン駆動機構 130の 可動部分にロードセル 142が配置されて 、な 、ので、その構造が簡単で生産性や信 頼性が良好である。  Further, in the chemical injection device 100 of the present embodiment, the piston drive mechanism 130 is supported by the head main body 113 so as to be displaceable, and the port cell 142 for detecting the pressure acting on the piston drive mechanism 130 is the head main body 113. It is fixed to. For this reason, since the load cell 142 is arranged in the movable part of the piston drive mechanism 130, the structure is simple and the productivity and reliability are good.
[0112] [実施の形態の変形例]  [0112] [Modification of Embodiment]
本発明は上記形態に限定されるものではなぐその要旨を逸脱しない範囲で各種 の変形を許容する。例えば、上記形態では造影剤注入機構 130Cおよび生理食塩 水注入機構 130Pを有する薬液注入装置 100が造影剤と生理食塩水とを注入するこ とを例示したが、 1個のピストン駆動機構 130で造影剤のみを注入する薬液注入装置 (図示せず)も実施可能である。  The present invention is not limited to the above embodiment, and various modifications are allowed without departing from the scope of the present invention. For example, in the above embodiment, the chemical injection device 100 having the contrast medium injection mechanism 130C and the physiological saline injection mechanism 130P is exemplified to inject the contrast medium and the physiological saline. A chemical solution injection device (not shown) for injecting only the agent can also be implemented.
[0113] また、上記形態では造影剤注入機構 130Cおよび生理食塩水注入機構 130Pを有 する薬液注入装置 100が生理食塩水で試験注入を実行することを例示した。しかし 、造影剤で試験注入を実行することも可能である。その場合、例えば、透視画像が撮 像される患部まで造影剤が到達する所要時間の確認のために特化されたピストン駆 動機構 130の制御データを試験注入の各種データとしてコンピュータユニット 120に 登録しておき、その制御データに対応してピストン駆動機構 130の動作を制御するこ とが可能である。 [0114] さらに、上記形態ではメインタツチパネル 104およびサブタツチパネル 118で正式 注入および試験注入の入力操作と表示とが実行されることを例示した。しかし、例え ば、独立したメインタツチパネルおよびサブディスプレイパネルと、メイン操作パネル およびサブ操作パネルとで、正式注入および試験注入の入力操作と表示とを個別に 実行することも可能である (図示せず)。 [0113] Further, in the above embodiment, the chemical injection device 100 having the contrast medium injection mechanism 130C and the physiological saline injection mechanism 130P performs the test injection with the physiological saline. However, it is also possible to perform a test injection with a contrast agent. In that case, for example, the control data of the piston drive mechanism 130 specialized for confirming the time required for the contrast medium to reach the affected part where the fluoroscopic image is taken is registered in the computer unit 120 as various data of the test injection. In addition, the operation of the piston drive mechanism 130 can be controlled in accordance with the control data. [0114] Further, in the above embodiment, it is exemplified that the main touch panel 104 and the sub touch panel 118 execute the input operation and display of formal injection and test injection. However, for example, it is also possible to separately perform the input operation and display of formal injection and test injection on the independent main touch panel and sub display panel and the main operation panel and sub operation panel (not shown). )
[0115] また、上記形態ではピストン部材 220の圧力を薬液の注入圧力に換算するために 必要な薬液シリンジ 200の各種データが、薬液注入装置 100に事前に登録されて ヽ ることを例示した。しかし、例えば、その各種データが記録されている RFIDタグが薬 液シリンジ 200に装着されており、その RFIDタグ力も記録されている各種データを取 得する RFIDリーダが薬液注入装置に搭載されていることも可能である (図示せず)。 この場合、新製品の薬液シリンジ 200が出荷されても、その各種データを薬液注入 装置 100が取得することができる。  [0115] Further, in the above embodiment, it has been exemplified that various data of the chemical syringe 200 necessary for converting the pressure of the piston member 220 into the injection pressure of the chemical solution is registered in the chemical injection device 100 in advance. However, for example, an RFID tag in which various data is recorded is attached to the chemical syringe 200, and an RFID reader that acquires various data in which the RFID tag force is recorded is mounted in the chemical injection device. Is also possible (not shown). In this case, even if the new chemical syringe 200 is shipped, the chemical injection device 100 can acquire various data thereof.
[0116] さらに、薬液注入装置 100が薬液シリンジ 200の製造メーカのホストコンピュータと オンラインで接続されており、新製品の薬液シリンジ 200が出荷されるごとに各種デ ータが薬液注入装置 100にオンラインで提供されるようなことも可能である (図示せず )。  [0116] Furthermore, the chemical injection device 100 is connected online to the host computer of the manufacturer of the chemical syringe 200, and various data are online to the chemical injection device 100 each time a new chemical syringe 200 is shipped. It is also possible to provide it with (not shown).
[0117] また、上記形態では薬液シリンジ 200の各種データによりピストン部材 220の圧力 を薬液の注入圧力に換算することを例示した。しかし、例えば、シリンダ部材 210や 延長チューブ 230の内部にロードセルを設置することにより (図示せず)、薬液の注入 圧力を直接検出することも可能である。  [0117] In the above embodiment, the pressure of the piston member 220 is converted into the injection pressure of the chemical liquid based on various data of the chemical liquid syringe 200. However, for example, by installing a load cell inside the cylinder member 210 or the extension tube 230 (not shown), it is possible to directly detect the injection pressure of the chemical solution.
[0118] さらに、上記形態では撮像部位ごとに少なくとも 1つの薬液シリンジ 200が登録され ており、登録されている薬液シリンジ 200が複数の場合には一覧表示して作業者に 選択操作させることを例示した。しかし、撮像部位ごとに薬液シリンジ 200が 1つのみ 登録されており、撮像部位が選択されるとシリンジデータが自動的に読み出されるこ とも可能である。  [0118] Furthermore, in the above embodiment, at least one chemical syringe 200 is registered for each imaging region, and when there are a plurality of registered chemical syringes 200, a list is displayed and an operator performs a selection operation. did. However, only one chemical syringe 200 is registered for each imaging region, and syringe data can be automatically read when an imaging region is selected.
[0119] また、上記形態では透視撮像装置として MRI装置 300を使用し、薬液注入装置 10 0が MR用の造影剤を注入することを例示した。しかし、例えば、透視撮像装置として CTスキャナや PET装置を使用し、それ用の造影剤を薬液注入装置が注入すること も可能である。 [0119] In the above embodiment, the MRI apparatus 300 is used as the fluoroscopic imaging apparatus, and the liquid injector 100 injects the MR contrast agent. However, for example, a CT scanner or PET device is used as a fluoroscopic imaging device, and a contrast medium for that is injected by a chemical injection device. Is also possible.
さらに、上記形態では RAM 123等に格納されているコンピュータプログラムに対応 して CPU 121が動作することにより、薬液注入装置 100の各種機能として各種手段 が論理的に実現されることを例示した。しかし、このような各種手段の各々を固有の ハードウェアとして形成することも可能であり、一部をソフトウェアとして RAM123等に 格納するとともに一部をノヽードウエアとして形成することも可能である。  Further, in the above embodiment, it is exemplified that various means are logically realized as various functions of the chemical injection device 100 by operating the CPU 121 corresponding to the computer program stored in the RAM 123 or the like. However, each of these various means can be formed as unique hardware, and a part thereof can be stored as software in the RAM 123 or the like and a part can be formed as nodeware.

Claims

請求の範囲 The scope of the claims
[1] シリンダ部材にピストン部材がスライド自在に挿入されて ヽる薬液シリンジカゝら延長 チューブを介して被験者に薬液を試験注入してカゝら正式注入する薬液注入装置で あって、  [1] A chemical solution injection device that performs a test injection of a chemical solution to a subject through an extension tube through which a piston member is slidably inserted into a cylinder member, and then officially injects the test solution.
前記シリンダ部材に前記ピストン部材を押し込むピストン駆動機構と、  A piston drive mechanism for pushing the piston member into the cylinder member;
前記被験者に注入される薬液の注入圧力を検出する圧力検出手段と、 前記試験注入の実行中に検出される前記注入圧力を経時グラフとしてリアルタイム に生成するグラフ生成手段と、  Pressure detection means for detecting an injection pressure of a chemical solution injected into the subject, and a graph generation means for generating the injection pressure detected during execution of the test injection in real time as a time graph;
前記試験注入が適正に実行されたときの前記注入圧力に相当する基準グラフを記 憶して!/、るグラフ記憶手段と、  A graph storage means for storing a reference graph corresponding to the injection pressure when the test injection is properly executed;
前記経時グラフの形状を前記基準グラフの形状とリアルタイムに比較するグラフ比 較手段と、  A graph comparing means for comparing the shape of the time-dependent graph with the shape of the reference graph in real time;
前記経時グラフの形状と前記基準グラフの形状とが類似しないと異常発生を検出 する異常検出手段と、  An abnormality detection means for detecting occurrence of an abnormality if the shape of the time-dependent graph and the shape of the reference graph are not similar;
を有して!/ヽる薬液注入装置。  Have a! / A chemical solution injection device.
[2] 前記経時グラフをリアルタイムに表示するグラフ表示手段と、 [2] Graph display means for displaying the time-lapse graph in real time;
前記異常検出手段を、入力操作により前記異常発生を検出した状態とする入力操 作手段と、  Input operation means for causing the abnormality detection means to be in a state where the occurrence of the abnormality is detected by an input operation; and
をさらに有して 、る請求項 1に記載の薬液注入装置。  The chemical injection device according to claim 1, further comprising:
[3] 前記経時グラフを前記基準グラフとともに表示するグラフ表示手段と、 [3] Graph display means for displaying the time-lapse graph together with the reference graph;
入力操作により前記経時グラフを前記基準グラフとして前記グラフ記憶手段に登録 するグラフ登録手段と、をさらに有している請求項 1に記載の薬液注入装置。  2. The drug solution injector according to claim 1, further comprising a graph registration unit that registers the time-lapse graph as the reference graph in the graph storage unit by an input operation.
[4] 前記ピストン駆動機構の動作を制御するとともに、少なくとも前記グラフ生成手段と 前記グラフ記憶手段と前記グラフ比較手段として機能するコンピュータユニットと、 前記コンピュータユニットによる各種データの表示を実行するメインディスプレイパ ネルと、 [4] A main display panel that controls the operation of the piston drive mechanism, and at least a computer unit that functions as the graph generation unit, the graph storage unit, and the graph comparison unit, and displays various data by the computer unit. Nell,
前記コンピュータユニットへの各種データの入力操作を受け付けるメイン操作パネ ルと、 前記メインディスプレイパネルより小型で前記コンピュータユニットによる各種データ の表示を実行するサブディスプレイパネルと、 A main operation panel for accepting various data input operations to the computer unit; A sub display panel that is smaller than the main display panel and displays various data by the computer unit;
前記メイン操作パネルより小型で前記コンピュータユニットへの各種データの入力 操作を受け付けるサブ操作パネルと、  A sub operation panel that is smaller than the main operation panel and accepts various data input operations to the computer unit;
少なくとも前記コンピュータユニットと前記メインディスプレイパネルと前記メイン操作 パネルとが搭載されて 、る注入制御ユニットと、  At least the computer unit, the main display panel, and the main operation panel are mounted on the injection control unit;
前記注入制御ユニットとは別体に構成されていて少なくとも前記ピストン駆動機構と 前記サブディスプレイパネルと前記サブ操作パネルとが搭載されている注入ヘッドと 、を有しており、  The injection control unit is configured separately from the injection control unit, and has at least the piston drive mechanism, the injection head on which the sub display panel and the sub operation panel are mounted,
前記正式注入の少なくとも一部のデータが前記メイン操作パネルで入力操作され るとともに前記メインディスプレイパネルで表示され、  At least a part of the data of the formal injection is input on the main operation panel and displayed on the main display panel,
前記試験注入の少なくとも一部のデータが前記サブ操作パネルで入力操作される とともに前記サブディスプレイパネルで表示される請求項 1な ヽし 3の何れか一項に 記載の薬液注入装置。  The chemical injection device according to any one of claims 1 to 3, wherein at least part of data of the test injection is input on the sub operation panel and displayed on the sub display panel.
[5] 前記コンピュータユニットは、人体の複数の身体区分と多数の撮像部位との模式画 像を関連させて記憶して 、るとともに前記撮像部位ごとに前記基準グラフを記憶して おり、  [5] The computer unit stores a schematic image of a plurality of body sections of a human body and a large number of imaging parts in association with each other, and stores the reference graph for each imaging part.
複数の前記身体区分の模式画像を前記人体形状に対応して前記メインディスプレ ィパネルが表示し、  The main display panel displays a plurality of schematic images of the body sections corresponding to the human body shape,
表示された複数の前記身体区分から 1つを選択する入力操作を前記メイン操作パ ネルが受け付け、  The main operation panel accepts an input operation for selecting one of the displayed body categories,
選択された前記身体区分に対応して少なくとも 1つの前記撮像部位の模式画像を 前記メインディスプレイパネルが表示し、  The main display panel displays at least one schematic image of the imaging region corresponding to the selected body segment,
表示された前記撮像部位から 1つを選定する入力操作を前記メイン操作パネルが 受け付け、  The main operation panel accepts an input operation for selecting one of the displayed imaging parts,
選定された前記撮像部位に対応した前記基準グラフが読み出されて前記サブディ スプレイパネルに表示される請求項 4に記載の薬液注入装置。  5. The chemical injection device according to claim 4, wherein the reference graph corresponding to the selected imaging region is read and displayed on the sub display panel.
[6] 前記薬液シリンジとして複数種類があり、 前記シリンダ部材に前記ピストン部材が押し込まれる圧力をリアルタイムに検出する 圧力検出素子をさらに有しており、 [6] There are multiple types of the drug solution syringe, A pressure detection element for detecting in real time the pressure with which the piston member is pushed into the cylinder member;
前記コンピュータユニットは、前記撮像部位ごとに前記薬液シリンジの各種データを 記憶しており、選定された前記撮像部位に対応して前記薬液シリンジの各種データ を読み出し、読み出した前記薬液シリンジの各種データにより前記圧力検出素子に より検出される圧力を前記薬液の注入圧力にリアルタイムに換算する請求項 5に記載 の薬液注入装置。  The computer unit stores various data of the chemical syringe for each imaging region, reads various data of the chemical syringe corresponding to the selected imaging region, and uses the read various data of the chemical syringe. 6. The chemical solution injection device according to claim 5, wherein the pressure detected by the pressure detection element is converted into the injection pressure of the chemical solution in real time.
[7] 前記薬液シリンジとして複数種類があり、 [7] There are multiple types of the drug solution syringe,
前記シリンダ部材に前記ピストン部材が押し込まれる圧力をリアルタイムに検出する 圧力検出素子をさらに有しており、  A pressure detection element for detecting in real time the pressure with which the piston member is pushed into the cylinder member;
前記コンピュータユニットが前記撮像部位ごとに少なくとも 1種類の前記薬液シリン ジの各種データを記憶しており、  The computer unit stores various data of at least one chemical syringe for each imaging region,
前記コンピュータユニットは、選定された前記撮像部位に対応して前記薬液シリン ジの各種データを読み出し、  The computer unit reads various data of the liquid syringe corresponding to the selected imaging region,
選択された前記撮像部位に対応して少なくとも 1種類の前記薬液シリンジの識別デ ータを前記メインディスプレイパネルおよび前記サブディスプレイパネルの少なくとも 一方が表示し、  At least one of the main display panel and the sub display panel displays identification data of at least one kind of the liquid syringe corresponding to the selected imaging region,
表示された前記識別データから 1つを選定する入力操作を前記メイン操作パネル および前記サブ操作パネルの少なくとも一方が受け付け、  At least one of the main operation panel and the sub operation panel accepts an input operation for selecting one from the displayed identification data,
前記コンピュータユニットは、選定された前記薬液シリンジの各種データにより前記 圧力検出素子により検出される圧力を前記薬液の注入圧力にリアルタイムに換算す る請求項 5に記載の薬液注入装置。  6. The chemical solution injection device according to claim 5, wherein the computer unit converts the pressure detected by the pressure detection element from the various data of the selected chemical solution syringe into the injection pressure of the chemical solution in real time.
[8] 各種データが記録されて前記薬液シリンジに装着されている RFID(Radio Frequen cy Identification)タグから、記録されている前記各種データを取得する RFIDリーダを さらに有しており、 [8] It further includes an RFID reader that acquires the various recorded data from an RFID (Radio Frequency Identification) tag in which various data is recorded and attached to the chemical syringe.
前記圧力検出手段は、前記シリンダ部材に前記ピストン部材が押し込まれる圧力を リアルタイムに検出する圧力検出素子と、前記圧力検出素子により検出される圧力を 前記 RFIDタグから取得された前記各種データにより前記薬液の注入圧力にリアルタ ィムに換算する圧力換算手段と、を有している請求項 1ないし 5の何れか一項に記載 の薬液注入装置。 The pressure detection means includes a pressure detection element that detects in real time a pressure at which the piston member is pushed into the cylinder member, and a pressure detected by the pressure detection element based on the various data acquired from the RFID tag. The injection pressure of realta The chemical injection device according to any one of claims 1 to 5, further comprising a pressure conversion means for converting into a fluid.
[9] 請求項 1に記載の薬液注入装置を用いたデータ処理方法であって、  [9] A data processing method using the chemical injection device according to claim 1,
前記試験注入が適正に実行されたときの注入圧力に相当する基準グラフを記憶し ておき、  A reference graph corresponding to the injection pressure when the test injection is properly executed is stored,
前記試験注入の実行中に検出される注入圧力を経時グラフとしてリアルタイムに生 成し、  The injection pressure detected during the execution of the test injection is generated in real time as a time graph,
前記経時グラフの形状を前記基準グラフの形状とリアルタイムに比較し、 前記経時グラフの形状と前記基準グラフの形状とが類似しないと異常発生を検出 するデータ処理方法。  A data processing method for comparing the shape of the time-dependent graph with the shape of the reference graph in real time, and detecting the occurrence of an abnormality if the shape of the time-dependent graph is not similar to the shape of the reference graph.
[10] 請求項 1に記載の薬液注入装置のためのコンピュータプログラムであって、 [10] A computer program for the chemical injection device according to claim 1,
前記試験注入が適正に実行されたときの注入圧力に相当する基準グラフを記憶し ておくこと、  Storing a reference graph corresponding to the injection pressure when the test injection is properly executed;
前記試験注入の実行中に検出される注入圧力を経時グラフとしてリアルタイムに生 成すること、  Generating the injection pressure detected during execution of the test injection in real time as a graph over time;
前記経時グラフの形状を前記基準グラフの形状とリアルタイムに比較すること、およ び  Comparing the shape of the time graph with the shape of the reference graph in real time; and
前記経時グラフの形状と前記基準グラフの形状とが類似しないと異常発生を検出 すること、  Detecting the occurrence of an abnormality if the shape of the graph over time and the shape of the reference graph are not similar;
を前記薬液注入装置に実行させるためのコンピュータプログラム。  Is a computer program for causing the medicinal solution injection device to execute.
PCT/JP2007/057494 2006-04-06 2007-04-03 Medical liquid injecting device WO2007114447A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008508704A JPWO2007114447A1 (en) 2006-04-06 2007-04-03 Chemical injection device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-105581 2006-04-06
JP2006105581 2006-04-06

Publications (1)

Publication Number Publication Date
WO2007114447A1 true WO2007114447A1 (en) 2007-10-11

Family

ID=38563711

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/057494 WO2007114447A1 (en) 2006-04-06 2007-04-03 Medical liquid injecting device

Country Status (2)

Country Link
JP (1) JPWO2007114447A1 (en)
WO (1) WO2007114447A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008126854A1 (en) * 2007-04-10 2008-10-23 Nemoto Kyorindo Co., Ltd. Chemical liquid injection device
WO2010014654A1 (en) * 2008-07-29 2010-02-04 Mallinckrodt Inc. Multi-syringe cassette
WO2010119919A1 (en) * 2009-04-15 2010-10-21 株式会社根本杏林堂 Chemical solution feeder
JP2011502702A (en) * 2007-11-19 2011-01-27 マリンクロッド・インコーポレイテッド Power injector with patency check using pressure monitoring
JP2013025098A (en) * 2011-07-21 2013-02-04 Icst:Kk Injector training device
JP2017109122A (en) * 2011-02-01 2017-06-22 株式会社根本杏林堂 Liquid medicine injection device
JP2022512141A (en) * 2018-12-10 2022-02-02 フェッター ファルマ-フェルティグング ゲーエムベーハー ウント コンパニー カーゲー Force measuring assemblies, force measuring devices with such force measuring assemblies and methods using such force measuring assemblies
JP2022512142A (en) * 2018-12-10 2022-02-02 フェッター ファルマ-フェルティグング ゲーエムベーハー ウント コンパニー カーゲー A mounting assembly for mounting a test device holder to a force measuring device, a force measuring device with such a mounting assembly, a test device holder and a slider member for the force measuring device.
US11369723B2 (en) * 2017-05-16 2022-06-28 Fresenius Medical Care Deutschland Gmbh Peritoneal dialysis machine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004298550A (en) * 2003-04-01 2004-10-28 Nemoto Kyorindo:Kk Chemical injection system
WO2005039675A1 (en) * 2003-10-29 2005-05-06 Nemoto Kyorindo Co., Ltd Medicinal liquid infusion apparatus
WO2005084732A1 (en) * 2004-03-03 2005-09-15 Nemoto Kyorindo Co., Ltd. Medical solution injection system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004298550A (en) * 2003-04-01 2004-10-28 Nemoto Kyorindo:Kk Chemical injection system
WO2005039675A1 (en) * 2003-10-29 2005-05-06 Nemoto Kyorindo Co., Ltd Medicinal liquid infusion apparatus
WO2005084732A1 (en) * 2004-03-03 2005-09-15 Nemoto Kyorindo Co., Ltd. Medical solution injection system

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008126854A1 (en) * 2007-04-10 2008-10-23 Nemoto Kyorindo Co., Ltd. Chemical liquid injection device
JP2011502702A (en) * 2007-11-19 2011-01-27 マリンクロッド・インコーポレイテッド Power injector with patency check using pressure monitoring
WO2010014654A1 (en) * 2008-07-29 2010-02-04 Mallinckrodt Inc. Multi-syringe cassette
WO2010119919A1 (en) * 2009-04-15 2010-10-21 株式会社根本杏林堂 Chemical solution feeder
JP2017109122A (en) * 2011-02-01 2017-06-22 株式会社根本杏林堂 Liquid medicine injection device
JP2021090794A (en) * 2011-02-01 2021-06-17 株式会社根本杏林堂 Medical solution injection device
US20140127661A1 (en) * 2011-07-21 2014-05-08 Icst Corporation Syringe operation practice device
JP2013025098A (en) * 2011-07-21 2013-02-04 Icst:Kk Injector training device
US11369723B2 (en) * 2017-05-16 2022-06-28 Fresenius Medical Care Deutschland Gmbh Peritoneal dialysis machine
JP2022512141A (en) * 2018-12-10 2022-02-02 フェッター ファルマ-フェルティグング ゲーエムベーハー ウント コンパニー カーゲー Force measuring assemblies, force measuring devices with such force measuring assemblies and methods using such force measuring assemblies
JP2022512142A (en) * 2018-12-10 2022-02-02 フェッター ファルマ-フェルティグング ゲーエムベーハー ウント コンパニー カーゲー A mounting assembly for mounting a test device holder to a force measuring device, a force measuring device with such a mounting assembly, a test device holder and a slider member for the force measuring device.
JP7439090B2 (en) 2018-12-10 2024-02-27 フェッター ファルマ-フェルティグング ゲーエムベーハー ウント コンパニー カーゲー Mounting assembly for mounting a test device holder on a force-measuring device, a force-measuring device with such a mounting assembly, a test device holder and a slider member for a force-measuring device
JP7439089B2 (en) 2018-12-10 2024-02-27 フェッター ファルマ-フェルティグング ゲーエムベーハー ウント コンパニー カーゲー Force-measuring assembly, force-measuring device with such a force-measuring assembly and method using such a force-measuring assembly
JP7576720B2 (en) 2018-12-10 2024-10-31 フェッター ファルマ-フェルティグング ゲーエムベーハー ウント コンパニー カーゲー Force measuring assembly, force measuring device equipped with such a force measuring assembly and method using such a force measuring assembly - Patents.com

Also Published As

Publication number Publication date
JPWO2007114447A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
JP4786344B2 (en) Chemical injection device
WO2007114447A1 (en) Medical liquid injecting device
JP7010513B2 (en) Chemical injection device and chemical injection system
US8437835B2 (en) Liquid injector displaying input injection condition as image
US20050049556A1 (en) Liquid injector in which a device for detecting the pressure exerted upon the liquid syringe piston is not arranged on a movable part
JP4982359B2 (en) Chemical injection system
JP4708189B2 (en) Chemical solution injection system for detecting attachment / detachment of a chemical solution syringe to / from a chemical solution injection device
JP5227791B2 (en) Chemical injection device
EP2671603B1 (en) Drug solution injection device
US8500677B2 (en) Power injector with flow rate assessment
WO2006059597A1 (en) Mechanical system
WO2009067212A1 (en) Power injector having patency check with pressure monitoring
EP1940490A1 (en) Powerhead control in a power injection system
JP4044779B2 (en) Chemical injection system
JPWO2006068171A1 (en) Chemical injection device
JP2003290348A (en) Injection apparatus adaptable to mri
JP4808213B2 (en) Chemical injection device
JP4481585B2 (en) Chemical injection device
JPWO2007116841A1 (en) Chemical injection system
JP4955744B2 (en) Chemical injection device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07740930

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008508704

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07740930

Country of ref document: EP

Kind code of ref document: A1